<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- RR Donnelley Xcelerate Instance Document, based on XBRL 2.1  http://www.rrdonnelley.com/ -->
<!-- Version:  6.22.4 -->
<!-- Round: 4 -->
<!-- Creation date: 2015-05-11T20:23:54Z -->
<!-- Copyright (c) 2005-2013 R.R. Donnelley &amp; Sons Company All Rights Reserved. -->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2014-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:mpw="http://www.medicalpropertiestrust.com/20150331" xmlns:us-types="http://fasb.org/us-types/2014-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2014-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2011-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:utr="http://www.xbrl.org/2009/utr">
  <xbrll:schemaRef xlink:type="simple" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="mpw-20150331.xsd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" />
  <invest:DerivativeNotionalAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20111031_0_910288x947542" unitRef="iso4217_USD" decimals="-6" id="id_6193307_03268AFE-C335-4DA9-BBF5-A854C9D795AD_5002_4">60000000</invest:DerivativeNotionalAmount>
  <us-gaap:CommonStockValueOutstanding contextRef="eol_PE631979--1510-Q0001_STD_0_20140131_0_901032x907457_907909x1026999" unitRef="iso4217_USD" decimals="INF" id="id_6193307_F519C380-3B89-42EC-9A48-D46B9613458B_2001_0">250000000</us-gaap:CommonStockValueOutstanding>
  <mpw:InterimAcquisitionLoan contextRef="eol_PE631979--1510-Q0001_STD_0_20150131_0_904377x1041555_907439x925328" unitRef="iso4217_EUR" decimals="-6" id="id_6193307_B8FF687D-3FED-45E6-88C9-96687B3E01C6_4002_1">425000000</mpw:InterimAcquisitionLoan>
  <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="eol_PE631979--1510-Q0001_STD_0_20150213_0_904377x1041555_904842x902958_907440x1082744" unitRef="iso4217_USD" decimals="-6" id="id_6193307_B726B940-59F5-42DF-8571-82E4719C5D01_2001_1">110000000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
  <mpw:NumberOfExtensionOptionsInCurrentLeaseContract contextRef="eol_PE631979--1510-Q0001_STD_0_20150213_0_904377x1041555_904842x902958_907440x1082744" unitRef="RenewalOptions" decimals="INF" id="id_6193307_B726B940-59F5-42DF-8571-82E4719C5D01_2001_3">2</mpw:NumberOfExtensionOptionsInCurrentLeaseContract>
  <dei:EntityCommonStockSharesOutstanding contextRef="eol_PE631979--1510-Q0001_STD_0_20150508_0" unitRef="shares" decimals="INF" id="id_6193307_6A94DFD6-FD91-454D-B669-5B289045196E_2_5">208915766</dei:EntityCommonStockSharesOutstanding>
  <us-gaap:ConvertibleDebt contextRef="eol_PE631979--1510-Q0001_STD_0_20120301_0" unitRef="iso4217_USD" decimals="-5" id="id_6193307_CC171053-2138-4DEA-8B37-91AF27184B83_1001_1">5000000</us-gaap:ConvertibleDebt>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableCurrent contextRef="eol_PE631979--1510-Q0001_STD_0_20130306_0_907439x1033784" unitRef="iso4217_USD" decimals="-5" id="id_6193307_1A7C66A4-C1FB-421A-A889-B6266D5082C3_1002_2">1100000</us-gaap:OperatingLeasesFutureMinimumPaymentsReceivableCurrent>
  <mpw:BusinessAcquisitionsCostOfAcquiredEntityPurchasePrice contextRef="eol_PE631979--1510-Q0001_STD_0_20130306_0_907439x1033784" unitRef="iso4217_USD" decimals="-5" id="id_6193307_1A7C66A4-C1FB-421A-A889-B6266D5082C3_1002_1">27200000</mpw:BusinessAcquisitionsCostOfAcquiredEntityPurchasePrice>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE631979--1510-Q0001_STD_0_20140311_0_907909x1068343" unitRef="shares" decimals="-5" id="id_6193307_0BFB620C-010C-4BB5-A0AF-AE1A96F895BF_2001_0">7700000</us-gaap:CommonStockSharesIssued>
  <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="eol_PE631979--1510-Q0001_STD_0_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1002_35">36032000</us-gaap:DividendsPayableCurrentAndNoncurrent>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE631979--1510-Q0001_STD_0_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1002_32">50309000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_607196C8-8F0B-49C3-BE09-20BB3032BDE8_2002_7">115000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:SaleOfStockPricePerShare contextRef="eol_PE631979--1510-Q0001_STD_0_20140331_0_902891x904047_907909x1026999" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_6193307_F519C380-3B89-42EC-9A48-D46B9613458B_3002_3">13.21</us-gaap:SaleOfStockPricePerShare>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20140331_0_907645x905205" unitRef="iso4217_USD" decimals="-3" id="id_6193307_607196C8-8F0B-49C3-BE09-20BB3032BDE8_3002_1">99602000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20140331_0_907645x907375" unitRef="iso4217_USD" decimals="-3" id="id_6193307_607196C8-8F0B-49C3-BE09-20BB3032BDE8_4002_0">8515000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20140331_0_907645x976566" unitRef="iso4217_USD" decimals="-3" id="id_6193307_607196C8-8F0B-49C3-BE09-20BB3032BDE8_7002_2">6883000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE631979--1510-Q0001_STD_0_20140331_0_907909x1026999" unitRef="shares" decimals="-5" id="id_6193307_F519C380-3B89-42EC-9A48-D46B9613458B_1002_2">900000</us-gaap:CommonStockSharesIssued>
  <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="eol_PE631979--1510-Q0001_STD_0_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_2002_35">36032000</us-gaap:DividendsPayableCurrentAndNoncurrent>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE631979--1510-Q0001_STD_0_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_2002_32">50309000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="shares" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_29">207731000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="shares" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_30">207731000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="shares" decimals="INF" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_28">250000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="shares" decimals="INF" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_25">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_27">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="shares" decimals="INF" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_24">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_23">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockValue contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" xsi:nil="true" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_22" />
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_19C20B49-1243-4461-927E-7200EE60980E_1001_3">314436000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
  <us-gaap:DeferredRevenueLeasesNet contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EDC3E3A9-9E43-48B2-BD7D-912834ED9995_1_2">1411576000</us-gaap:DeferredRevenueLeasesNet>
  <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1001_35">46026000</us-gaap:DividendsPayableCurrentAndNoncurrent>
  <us-gaap:CommonStockValue contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_26">207000</us-gaap:CommonStockValue>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_33">-80922000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_17">111187000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_32">-371459000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:LongTermDebtFairValue contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_831C485D-B8C5-4B12-B724-1934097123F8_1001_2">1981158000</us-gaap:LongTermDebtFairValue>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_1001_9">1882319000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:StockholdersEquity contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_35">1795701000</us-gaap:StockholdersEquity>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_19C20B49-1243-4461-927E-7200EE60980E_1001_4">125000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_36">3823049000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:AdditionalPaidInCapital contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_31">2248137000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_19C20B49-1243-4461-927E-7200EE60980E_1001_1">125299000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
  <us-gaap:Liabilities contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_20">2027348000</us-gaap:Liabilities>
  <us-gaap:DeferredRevenue contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_18">25362000</us-gaap:DeferredRevenue>
  <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_19C20B49-1243-4461-927E-7200EE60980E_1001_2">320000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
  <us-gaap:LongTermDebt contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_19C20B49-1243-4461-927E-7200EE60980E_1001_6">1879886000</us-gaap:LongTermDebt>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_8">33548000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsReceivable contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EDC3E3A9-9E43-48B2-BD7D-912834ED9995_1_0">1639128000</us-gaap:CapitalLeasesFutureMinimumPaymentsReceivable>
  <us-gaap:InvestmentOwnedAtCost contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_66483850-7E5A-4521-9123-BC829506E4AA_1004_2">205750000</us-gaap:InvestmentOwnedAtCost>
  <us-gaap:ReceivablesFairValueDisclosure contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_831C485D-B8C5-4B12-B724-1934097123F8_1001_0">40324000</us-gaap:ReceivablesFairValueDisclosure>
  <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_3">437591000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
  <us-gaap:InvestmentOwnedAtFairValue contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_66483850-7E5A-4521-9123-BC829506E4AA_1004_1">205750000</us-gaap:InvestmentOwnedAtFairValue>
  <us-gaap:NetInvestmentInDirectFinancingAndSalesTypeLeases contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EDC3E3A9-9E43-48B2-BD7D-912834ED9995_1_3">453423000</us-gaap:NetInvestmentInDirectFinancingAndSalesTypeLeases>
  <us-gaap:OtherAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_12">122081000</us-gaap:OtherAssets>
  <us-gaap:Assets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_13">3823049000</us-gaap:Assets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_607196C8-8F0B-49C3-BE09-20BB3032BDE8_2001_7">165700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:LoansHeldForSaleFairValueDisclosure contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_831C485D-B8C5-4B12-B724-1934097123F8_1001_1">867523000</us-gaap:LoansHeldForSaleFairValueDisclosure>
  <us-gaap:LoansReceivableNet contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_988FD5A8-26FE-4194-A91D-584CAD3DE491_2004_1">1039548000</us-gaap:LoansReceivableNet>
  <us-gaap:TreasuryStockValue contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_34">262000</us-gaap:TreasuryStockValue>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_2014_1">152204000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:EstimatedResidualValues contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EDC3E3A9-9E43-48B2-BD7D-912834ED9995_1_1">225871000</mpw:EstimatedResidualValues>
  <mpw:GrossInvestmentInRealEstateAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_5">3178038000</mpw:GrossInvestmentInRealEstateAssets>
  <mpw:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_19C20B49-1243-4461-927E-7200EE60980E_1001_5">1314620000</mpw:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFiveAndThereafter>
  <mpw:LeaseDepositsAndOtherObligationsToTenants contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_19">8480000</mpw:LeaseDepositsAndOtherObligationsToTenants>
  <mpw:LongTermDebtMaturitiesRepaymentsOfPrincipalInPreviousFiscalYear contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_19C20B49-1243-4461-927E-7200EE60980E_1001_0">211000</mpw:LongTermDebtMaturitiesRepaymentsOfPrincipalInPreviousFiscalYear>
  <mpw:OtherLoans contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_11">601957000</mpw:OtherLoans>
  <mpw:AccumulatedDepreciationAndAmortization contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_6">216629000</mpw:AccumulatedDepreciationAndAmortization>
  <mpw:InterestAndRentReceivable contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_76C127EC-8D38-4F96-9948-506C403591A4_1001_0">40464000</mpw:InterestAndRentReceivable>
  <mpw:RemainingConvertibleDebtAfterConversionOfPartOfDebt contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-5" id="id_6193307_CC171053-2138-4DEA-8B37-91AF27184B83_1002_3">3300000</mpw:RemainingConvertibleDebtAfterConversionOfPartOfDebt>
  <mpw:NetInvestmentInRealEstateAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_7">2961409000</mpw:NetInvestmentInRealEstateAssets>
  <mpw:Loans contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_76C127EC-8D38-4F96-9948-506C403591A4_1001_1">837098000</mpw:Loans>
  <mpw:StraightLineRentReceivable contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_10">63590000</mpw:StraightLineRentReceivable>
  <mpw:LandBuildingsAndImprovementsAndIntangibleLeaseAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_1_2">2287024000</mpw:LandBuildingsAndImprovementsAndIntangibleLeaseAssets>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_901822x999402" unitRef="shares" decimals="INF" id="id_6193307_BCB9992F-BF99-4537-BC41-60A8F45FA231_1001_0">7643651</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_901822x999402" unitRef="shares" decimals="INF" id="id_6193307_BCB9992F-BF99-4537-BC41-60A8F45FA231_1001_1">5417878</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:InvestmentOwnedAtCost contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_902967x1024957_906116x904172_907181x905531" unitRef="iso4217_USD" decimals="-3" id="id_6193307_66483850-7E5A-4521-9123-BC829506E4AA_1001_2">100000000</us-gaap:InvestmentOwnedAtCost>
  <us-gaap:InvestmentOwnedAtFairValue contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_902967x1024957_906116x904172_907181x905531" unitRef="iso4217_USD" decimals="-3" id="id_6193307_66483850-7E5A-4521-9123-BC829506E4AA_1001_1">100000000</us-gaap:InvestmentOwnedAtFairValue>
  <us-gaap:InvestmentOwnedAtCost contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_902967x929995_907178x929207_907181x905531" unitRef="iso4217_USD" decimals="-3" id="id_6193307_66483850-7E5A-4521-9123-BC829506E4AA_1002_2">102450000</us-gaap:InvestmentOwnedAtCost>
  <us-gaap:InvestmentOwnedAtFairValue contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_902967x929995_907178x929207_907181x905531" unitRef="iso4217_USD" decimals="-3" id="id_6193307_66483850-7E5A-4521-9123-BC829506E4AA_1002_1">102450000</us-gaap:InvestmentOwnedAtFairValue>
  <us-gaap:LoansReceivableNet contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_903417x1061338" unitRef="iso4217_USD" decimals="-3" id="id_6193307_988FD5A8-26FE-4194-A91D-584CAD3DE491_2003_1">46566000</us-gaap:LoansReceivableNet>
  <us-gaap:LoansReceivableNet contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_903417x929207" unitRef="iso4217_USD" decimals="-3" id="id_6193307_988FD5A8-26FE-4194-A91D-584CAD3DE491_2002_1">555391000</us-gaap:LoansReceivableNet>
  <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_903455x912287" unitRef="iso4217_USD" decimals="-3" id="id_6193307_B731A478-AF2A-43DD-B914-672A7C1FA26B_1_1">264397000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
  <mpw:NumberOfFacilitiesLeased contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_904377x1012489_907439x963808" unitRef="Facility" decimals="INF" id="id_6193307_12C16D7E-81A6-4EC1-A8DD-CD9A860C2765_1001_0">2</mpw:NumberOfFacilitiesLeased>
  <mpw:NumberOfFacilitiesLeased contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_904377x1012489_907439x963808_907645x901808" unitRef="Facility" decimals="INF" id="id_6193307_BD218003-11A4-432B-B807-B10166A62539_1001_0">6</mpw:NumberOfFacilitiesLeased>
  <us-gaap:MortgageLoansOnRealEstate contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_904377x925328" unitRef="iso4217_USD" decimals="-5" id="id_6193307_909876A9-8D9E-42A1-801C-B73262B3A1EB_1002_0">442400000</us-gaap:MortgageLoansOnRealEstate>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1085855_907440x1085859_908021x1085858_908505x1087026" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_2001_1">8653000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1092391_907440x1082744_908021x991433_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_2013_1">13448000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1093693_907440x1082744_908021x1093700_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_2007_1">35820000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1093695_907440x1082744_908021x1093701_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_2002_1">5049000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1093696_907440x1082744_908021x1093702_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_2003_1">5754000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1093697_907440x1082744_908021x997679_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_2004_1">5123000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1093698_907440x1082744_908021x1093703_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_2010_1">4750000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1295244_907440x1082744_908021x1295250_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_2005_1">5273000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1295245_907440x1082744_908021x1082740_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_2006_1">6110000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1295245_907440x1082744_908021x1295251_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_2008_1">6500000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1295247_907440x1082744_908021x1295252_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_2009_1">4824000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1295248_907440x1082744_908021x1082740_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_2011_1">4939000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <mpw:DevelopmentProjectsOriginalCommitmentAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1295249_907440x1082744_908021x1082740_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_2012_1">45961000</mpw:DevelopmentProjectsOriginalCommitmentAmount>
  <us-gaap:VariableInterestEntityConsolidatedCarryingAmountAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_906604x1067963" unitRef="iso4217_USD" decimals="-3" id="id_6193307_E3EF825C-FBCD-45E7-B218-5877DC2A68E2_1_1">212196000</us-gaap:VariableInterestEntityConsolidatedCarryingAmountAssets>
  <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_907178x902141" unitRef="iso4217_USD" decimals="-3" id="id_6193307_B731A478-AF2A-43DD-B914-672A7C1FA26B_2_1">59228000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
  <us-gaap:InvestmentOwnedAtCost contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_907178x902141_907181x905531_910113x905894" unitRef="iso4217_USD" decimals="-3" id="id_6193307_66483850-7E5A-4521-9123-BC829506E4AA_1003_2">3300000</us-gaap:InvestmentOwnedAtCost>
  <us-gaap:InvestmentOwnedAtFairValue contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_907178x902141_907181x905531_910113x905894" unitRef="iso4217_USD" decimals="-3" id="id_6193307_66483850-7E5A-4521-9123-BC829506E4AA_1003_1">3300000</us-gaap:InvestmentOwnedAtFairValue>
  <mpw:LetterOfCreditToCoverFutureLeaseObligations contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_907439x1033784" unitRef="iso4217_USD" decimals="-5" id="id_6193307_1A7C66A4-C1FB-421A-A889-B6266D5082C3_1001_0">1200000</mpw:LetterOfCreditToCoverFutureLeaseObligations>
  <us-gaap:MortgageLoansOnRealEstate contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_907439x1040992" unitRef="iso4217_USD" decimals="-5" id="id_6193307_909876A9-8D9E-42A1-801C-B73262B3A1EB_1001_0">102500000</us-gaap:MortgageLoansOnRealEstate>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_907645x905205" unitRef="iso4217_USD" decimals="-3" id="id_6193307_607196C8-8F0B-49C3-BE09-20BB3032BDE8_3001_1">88409000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_907645x907375" unitRef="iso4217_USD" decimals="-3" id="id_6193307_607196C8-8F0B-49C3-BE09-20BB3032BDE8_4001_0">21591000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_907645x929480" unitRef="iso4217_USD" decimals="-3" id="id_6193307_607196C8-8F0B-49C3-BE09-20BB3032BDE8_5001_5">10700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_907645x929995" unitRef="iso4217_USD" decimals="-3" id="id_6193307_607196C8-8F0B-49C3-BE09-20BB3032BDE8_6001_6">5000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:RealEstateInvestments contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_907676x1295251" unitRef="iso4217_USD" decimals="-5" id="id_6193307_FA818C7A-7A7B-4C76-A061-35191336ED1C_2001_3">14100000</us-gaap:RealEstateInvestments>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_907909x1026999" unitRef="shares" decimals="-5" id="id_6193307_F519C380-3B89-42EC-9A48-D46B9613458B_1003_2">0</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonUnitIssued contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_907910x901931_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_1001_28">205659000</us-gaap:CommonUnitIssued>
  <us-gaap:CommonUnitOutstanding contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_907910x901931_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_1001_29">205659000</us-gaap:CommonUnitOutstanding>
  <us-gaap:LimitedPartnersCapitalAccount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_907910x901931_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_1001_27">1858231000</us-gaap:LimitedPartnersCapitalAccount>
  <mpw:MaximumPercentageOfEntitysNetAssetsInvestedOnSingleProperty contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_908551x905169" unitRef="pure" decimals="INF" id="id_6193307_438D498A-A844-4C37-8ABD-B8B7CDAF5B23_1001_1">0.04</mpw:MaximumPercentageOfEntitysNetAssetsInvestedOnSingleProperty>
  <mpw:NumberOfInvestments contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_908551x905169" unitRef="Investment" decimals="INF" id="id_6193307_438D498A-A844-4C37-8ABD-B8B7CDAF5B23_1001_0">0</mpw:NumberOfInvestments>
  <us-gaap:VariableInterestEntityConsolidatedCarryingAmountAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_910113x905894" unitRef="iso4217_USD" decimals="-3" id="id_6193307_E3EF825C-FBCD-45E7-B218-5877DC2A68E2_2_1">5324000</us-gaap:VariableInterestEntityConsolidatedCarryingAmountAssets>
  <us-gaap:PledgedAssetsSeparatelyReportedOtherAssetsPledgedAsCollateralAtFairValue contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_910288x904022" unitRef="iso4217_USD" decimals="-5" id="id_6193307_11F125AA-AEED-455B-A1CA-C93F4D4A3DC0_1001_0">2800000</us-gaap:PledgedAssetsSeparatelyReportedOtherAssetsPledgedAsCollateralAtFairValue>
  <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_910288x910614" unitRef="iso4217_USD" decimals="-5" id="id_6193307_03268AFE-C335-4DA9-BBF5-A854C9D795AD_4003_1">5500000</us-gaap:DerivativeFairValueOfDerivativeLiability>
  <us-gaap:DerivativeVariableInterestRate contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_910288x998346" unitRef="pure" decimals="INF" id="id_6193307_03268AFE-C335-4DA9-BBF5-A854C9D795AD_2003_2">0.05507</us-gaap:DerivativeVariableInterestRate>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_910720x1015151" unitRef="pure" decimals="INF" id="id_6193307_5EAC5479-4C0D-4410-BFF1-F5BC062D19CC_4001_3">0.06375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_910720x1015151" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_2001_5">352433000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentUnamortizedPremium contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_910720x1015151" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_2001_4">2433000</us-gaap:DebtInstrumentUnamortizedPremium>
  <us-gaap:LongTermDebt contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_910720x1015151" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_2001_3">350000000</us-gaap:LongTermDebt>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_910720x1049647" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_3001_8">138611000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_910720x1082633" unitRef="pure" decimals="INF" id="id_6193307_5EAC5479-4C0D-4410-BFF1-F5BC062D19CC_5001_6">0.05500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_910720x1082633" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_4001_7">300000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_910720x901310" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_5001_1">125000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_910720x912276" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_6001_0">301655000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_910720x975098" unitRef="pure" decimals="INF" id="id_6193307_5EAC5479-4C0D-4410-BFF1-F5BC062D19CC_6001_5">0.05750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_910720x975098" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_7001_6">214620000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_911379x904172" unitRef="iso4217_USD" decimals="-3" id="id_6193307_607196C8-8F0B-49C3-BE09-20BB3032BDE8_8001_4">40000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
  <us-gaap:LoansReceivableNet contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_911379x904172" unitRef="iso4217_USD" decimals="-3" id="id_6193307_988FD5A8-26FE-4194-A91D-584CAD3DE491_2001_1">437591000</us-gaap:LoansReceivableNet>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_911970x911063" unitRef="pure" decimals="INF" id="id_6193307_5EAC5479-4C0D-4410-BFF1-F5BC062D19CC_7001_2">0.06875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_911970x911063" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_8001_2">450000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912455x1012147_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_2001_32">292000</us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding>
  <us-gaap:LimitedPartnersCapitalAccountUnitsIssued contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912455x1012147_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_2001_31">292000</us-gaap:LimitedPartnersCapitalAccountUnitsIssued>
  <us-gaap:LimitedPartnersCapitalAccount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912455x1012147_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_2001_30">0</us-gaap:LimitedPartnersCapitalAccount>
  <us-gaap:GeneralPartnersCapitalAccountUnitsIssued contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912455x903927_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_3001_24">2072000</us-gaap:GeneralPartnersCapitalAccountUnitsIssued>
  <us-gaap:GeneralPartnersCapitalAccountUnitsOutstanding contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912455x903927_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_3001_25">2072000</us-gaap:GeneralPartnersCapitalAccountUnitsOutstanding>
  <us-gaap:GeneralPartnersCapitalAccount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912455x903927_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_3001_23">18782000</us-gaap:GeneralPartnersCapitalAccount>
  <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="pure" decimals="INF" id="id_6193307_521DB8E0-9F6D-49E8-9A0A-0EFF0FDDA678_4001_0">0.998</us-gaap:EquityMethodInvestmentOwnershipPercentage>
  <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_2001_35">46026000</us-gaap:DividendsPayableCurrentAndNoncurrent>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_33">-80922000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_17">65232000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_16">1882319000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:StockholdersEquity contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_34">1796091000</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_35">3823049000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:Liabilities contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_21">2026958000</us-gaap:Liabilities>
  <us-gaap:DeferredRevenue contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_18">25362000</us-gaap:DeferredRevenue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_8">33548000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_3">437591000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
  <us-gaap:NetInvestmentInDirectFinancingAndSalesTypeLeases contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_4">453423000</us-gaap:NetInvestmentInDirectFinancingAndSalesTypeLeases>
  <us-gaap:OtherAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_12">122081000</us-gaap:OtherAssets>
  <us-gaap:Assets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_13">3823049000</us-gaap:Assets>
  <mpw:GrossInvestmentInRealEstateAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_5">3178038000</mpw:GrossInvestmentInRealEstateAssets>
  <mpw:LeaseDepositsAndOtherObligationsToTenants contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_19">8480000</mpw:LeaseDepositsAndOtherObligationsToTenants>
  <mpw:OtherLoans contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_11">601957000</mpw:OtherLoans>
  <mpw:AccumulatedDepreciationAndAmortization contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_6">216629000</mpw:AccumulatedDepreciationAndAmortization>
  <mpw:InterestAndRentReceivable contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_9">40464000</mpw:InterestAndRentReceivable>
  <mpw:PayableDueToParentCompany contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_20">45565000</mpw:PayableDueToParentCompany>
  <mpw:NetInvestmentInRealEstateAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_7">2961409000</mpw:NetInvestmentInRealEstateAssets>
  <mpw:StraightLineRentReceivable contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_10">63590000</mpw:StraightLineRentReceivable>
  <mpw:LandBuildingsAndImprovementsAndIntangibleLeaseAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4001_2">2287024000</mpw:LandBuildingsAndImprovementsAndIntangibleLeaseAssets>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE631979--1510-Q0001_STD_0_20131231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2001_31">45979000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE631979--1510-Q0001_STD_0_20131231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_3001_31">45979000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="shares" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_29">172743000</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="shares" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_30">172743000</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesAuthorized contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_28">250000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:PreferredStockSharesOutstanding contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_25">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_27">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="shares" decimals="INF" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_24">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_23">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockValue contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" xsi:nil="true" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_22" />
  <us-gaap:DeferredRevenueLeasesNet contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EDC3E3A9-9E43-48B2-BD7D-912834ED9995_2_2">1379396000</us-gaap:DeferredRevenueLeasesNet>
  <us-gaap:CommonStockValue contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_26">172000</us-gaap:CommonStockValue>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_33">-21914000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_17">112623000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_32">-361330000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:LongTermDebtFairValue contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_831C485D-B8C5-4B12-B724-1934097123F8_1002_2">2285727000</us-gaap:LongTermDebtFairValue>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_1002_9">2201654000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:StockholdersEquity contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_35">1382047000</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_36">3747336000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:AdditionalPaidInCapital contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_31">1765381000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:Liabilities contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_20">2365289000</us-gaap:Liabilities>
  <us-gaap:DeferredRevenue contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_18">27207000</us-gaap:DeferredRevenue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_8">144541000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CapitalLeasesFutureMinimumPaymentsReceivable contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EDC3E3A9-9E43-48B2-BD7D-912834ED9995_2_0">1607024000</us-gaap:CapitalLeasesFutureMinimumPaymentsReceivable>
  <us-gaap:ReceivablesFairValueDisclosure contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_831C485D-B8C5-4B12-B724-1934097123F8_1002_0">41005000</us-gaap:ReceivablesFairValueDisclosure>
  <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_3">397594000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
  <us-gaap:NetInvestmentInDirectFinancingAndSalesTypeLeases contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EDC3E3A9-9E43-48B2-BD7D-912834ED9995_2_3">439516000</us-gaap:NetInvestmentInDirectFinancingAndSalesTypeLeases>
  <us-gaap:OtherAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_12">122105000</us-gaap:OtherAssets>
  <us-gaap:Assets contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_13">3747336000</us-gaap:Assets>
  <us-gaap:LoansHeldForSaleFairValueDisclosure contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_831C485D-B8C5-4B12-B724-1934097123F8_1002_1">803824000</us-gaap:LoansHeldForSaleFairValueDisclosure>
  <us-gaap:LoansReceivableNet contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_988FD5A8-26FE-4194-A91D-584CAD3DE491_1004_2">970761000</us-gaap:LoansReceivableNet>
  <us-gaap:TreasuryStockValue contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_34">262000</us-gaap:TreasuryStockValue>
  <mpw:EstimatedResidualValues contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EDC3E3A9-9E43-48B2-BD7D-912834ED9995_2_1">211888000</mpw:EstimatedResidualValues>
  <mpw:GrossInvestmentInRealEstateAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_5">3009885000</mpw:GrossInvestmentInRealEstateAssets>
  <mpw:LeaseDepositsAndOtherObligationsToTenants contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_19">23805000</mpw:LeaseDepositsAndOtherObligationsToTenants>
  <mpw:OtherLoans contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_11">573167000</mpw:OtherLoans>
  <mpw:AccumulatedDepreciationAndAmortization contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_6">202627000</mpw:AccumulatedDepreciationAndAmortization>
  <mpw:InterestAndRentReceivable contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_76C127EC-8D38-4F96-9948-506C403591A4_1002_0">41137000</mpw:InterestAndRentReceivable>
  <mpw:NetInvestmentInRealEstateAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_7">2807258000</mpw:NetInvestmentInRealEstateAssets>
  <mpw:Loans contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_76C127EC-8D38-4F96-9948-506C403591A4_1002_1">773311000</mpw:Loans>
  <mpw:StraightLineRentReceivable contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_10">59128000</mpw:StraightLineRentReceivable>
  <mpw:LandBuildingsAndImprovementsAndIntangibleLeaseAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EC451B15-BE58-4102-8112-9781B902E78C_2_2">2172775000</mpw:LandBuildingsAndImprovementsAndIntangibleLeaseAssets>
  <us-gaap:LoansReceivableNet contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_903417x1061338" unitRef="iso4217_USD" decimals="-3" id="id_6193307_988FD5A8-26FE-4194-A91D-584CAD3DE491_1003_2">48031000</us-gaap:LoansReceivableNet>
  <us-gaap:LoansReceivableNet contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_903417x929207" unitRef="iso4217_USD" decimals="-3" id="id_6193307_988FD5A8-26FE-4194-A91D-584CAD3DE491_1002_2">525136000</us-gaap:LoansReceivableNet>
  <us-gaap:CommonUnitIssued contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_907910x901931_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_1002_28">171021000</us-gaap:CommonUnitIssued>
  <us-gaap:CommonUnitOutstanding contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_907910x901931_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_1002_29">171021000</us-gaap:CommonUnitOutstanding>
  <us-gaap:LimitedPartnersCapitalAccount contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_907910x901931_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_1002_27">1390296000</us-gaap:LimitedPartnersCapitalAccount>
  <us-gaap:PledgedAssetsSeparatelyReportedOtherAssetsPledgedAsCollateralAtFairValue contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_910288x904022" unitRef="iso4217_USD" decimals="-5" id="id_6193307_11F125AA-AEED-455B-A1CA-C93F4D4A3DC0_1002_0">3300000</us-gaap:PledgedAssetsSeparatelyReportedOtherAssetsPledgedAsCollateralAtFairValue>
  <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_910288x910614" unitRef="iso4217_USD" decimals="-5" id="id_6193307_03268AFE-C335-4DA9-BBF5-A854C9D795AD_4004_1">6000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_910720x1015151" unitRef="pure" decimals="INF" id="id_6193307_5EAC5479-4C0D-4410-BFF1-F5BC062D19CC_4002_3">0.06375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_910720x1015151" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_2002_5">352522000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentUnamortizedPremium contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_910720x1015151" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_2002_4">2522000</us-gaap:DebtInstrumentUnamortizedPremium>
  <us-gaap:LongTermDebt contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_910720x1015151" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_2002_3">350000000</us-gaap:LongTermDebt>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_910720x1049647" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_3002_8">138682000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_910720x1082633" unitRef="pure" decimals="INF" id="id_6193307_5EAC5479-4C0D-4410-BFF1-F5BC062D19CC_5002_6">0.05500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_910720x1082633" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_4002_7">300000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_910720x901310" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_5002_1">125000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_910720x912276" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_6002_0">593490000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_910720x975098" unitRef="pure" decimals="INF" id="id_6193307_5EAC5479-4C0D-4410-BFF1-F5BC062D19CC_6002_5">0.05750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_910720x975098" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_7002_6">241960000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:LoansReceivableNet contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_911379x904172" unitRef="iso4217_USD" decimals="-3" id="id_6193307_988FD5A8-26FE-4194-A91D-584CAD3DE491_1001_2">397594000</us-gaap:LoansReceivableNet>
  <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_911970x911063" unitRef="pure" decimals="INF" id="id_6193307_5EAC5479-4C0D-4410-BFF1-F5BC062D19CC_7002_2">0.06875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_911970x911063" unitRef="iso4217_USD" decimals="-3" id="id_6193307_3648F812-BA81-4417-BD64-E01AB845EB28_8002_2">450000000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912455x1012147_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_2002_32">292000</us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding>
  <us-gaap:LimitedPartnersCapitalAccountUnitsIssued contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912455x1012147_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_2002_31">292000</us-gaap:LimitedPartnersCapitalAccountUnitsIssued>
  <us-gaap:LimitedPartnersCapitalAccount contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912455x1012147_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_2002_30">0</us-gaap:LimitedPartnersCapitalAccount>
  <us-gaap:GeneralPartnersCapitalAccountUnitsIssued contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912455x903927_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_3002_24">1722000</us-gaap:GeneralPartnersCapitalAccountUnitsIssued>
  <us-gaap:GeneralPartnersCapitalAccountUnitsOutstanding contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912455x903927_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_3002_25">1722000</us-gaap:GeneralPartnersCapitalAccountUnitsOutstanding>
  <us-gaap:GeneralPartnersCapitalAccount contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912455x903927_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_3002_23">14055000</us-gaap:GeneralPartnersCapitalAccount>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_33">-21914000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_17">74195000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
  <us-gaap:DebtInstrumentCarryingAmount contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_16">2201654000</us-gaap:DebtInstrumentCarryingAmount>
  <us-gaap:StockholdersEquity contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_34">1382437000</us-gaap:StockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_35">3747336000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:Liabilities contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_21">2364899000</us-gaap:Liabilities>
  <us-gaap:DeferredRevenue contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_18">27207000</us-gaap:DeferredRevenue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_8">144541000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_3">397594000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
  <us-gaap:NetInvestmentInDirectFinancingAndSalesTypeLeases contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_4">439516000</us-gaap:NetInvestmentInDirectFinancingAndSalesTypeLeases>
  <us-gaap:OtherAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_12">122105000</us-gaap:OtherAssets>
  <us-gaap:Assets contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_13">3747336000</us-gaap:Assets>
  <mpw:GrossInvestmentInRealEstateAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_5">3009885000</mpw:GrossInvestmentInRealEstateAssets>
  <mpw:LeaseDepositsAndOtherObligationsToTenants contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_19">23805000</mpw:LeaseDepositsAndOtherObligationsToTenants>
  <mpw:OtherLoans contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_11">573167000</mpw:OtherLoans>
  <mpw:AccumulatedDepreciationAndAmortization contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_6">202627000</mpw:AccumulatedDepreciationAndAmortization>
  <mpw:InterestAndRentReceivable contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_9">41137000</mpw:InterestAndRentReceivable>
  <mpw:PayableDueToParentCompany contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_20">38038000</mpw:PayableDueToParentCompany>
  <mpw:NetInvestmentInRealEstateAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_7">2807258000</mpw:NetInvestmentInRealEstateAssets>
  <mpw:StraightLineRentReceivable contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_10">59128000</mpw:StraightLineRentReceivable>
  <mpw:LandBuildingsAndImprovementsAndIntangibleLeaseAssets contextRef="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_075A9D54-7FB2-42A5-B7F1-A1FA32165D00_4002_2">2172775000</mpw:LandBuildingsAndImprovementsAndIntangibleLeaseAssets>
  <us-gaap:CommonStockSharesIssued contextRef="eol_PE631979--1510-Q0001_STD_0_20150114_0_907909x1068343" unitRef="shares" decimals="-5" id="id_6193307_FED8C849-CE97-4795-8F36-8327727D0B39_2001_0">34500000</us-gaap:CommonStockSharesIssued>
  <mpw:RemainingPortionOfInterimAcquisitionLoansAdvancedToAcquiredEntity contextRef="eol_PE631979--1510-Q0001_STD_1_20150131_0_904377x1041555_907439x925328" unitRef="iso4217_EUR" decimals="-5" id="id_6193307_B8FF687D-3FED-45E6-88C9-96687B3E01C6_3002_0">63100000</mpw:RemainingPortionOfInterimAcquisitionLoansAdvancedToAcquiredEntity>
  <us-gaap:NumberOfBusinessesAcquired contextRef="eol_PE631979--1510-Q0001_STD_1_20150213_0_904377x1041555_904842x902958_907440x1082744" unitRef="Facility" decimals="INF" id="id_6193307_B726B940-59F5-42DF-8571-82E4719C5D01_1001_0">2</us-gaap:NumberOfBusinessesAcquired>
  <us-gaap:DebtInstrumentTerm contextRef="eol_PE631979--1510-Q0001_STD_1_20150213_0_904377x1041555_904842x902958_907440x1082744" id="id_6193307_B726B940-59F5-42DF-8571-82E4719C5D01_1001_6">P10Y</us-gaap:DebtInstrumentTerm>
  <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans contextRef="eol_PE631979--1510-Q0001_STD_1_20150213_0_904377x1041555_904842x902958_907440x1082744" unitRef="iso4217_USD" decimals="-6" id="id_6193307_B726B940-59F5-42DF-8571-82E4719C5D01_1001_5">40000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
  <mpw:LeasePeriod contextRef="eol_PE631979--1510-Q0001_STD_1_20150213_0_904377x1041555_904842x902958_907440x1082744" id="id_6193307_B726B940-59F5-42DF-8571-82E4719C5D01_1001_2">P10Y</mpw:LeasePeriod>
  <mpw:LeaseExtensionPeriod contextRef="eol_PE631979--1510-Q0001_STD_1_20150213_0_904377x1041555_904842x902958_907440x1082744" id="id_6193307_B726B940-59F5-42DF-8571-82E4719C5D01_1001_4">P5Y</mpw:LeaseExtensionPeriod>
  <us-gaap:PaymentsToFundLongtermLoansToRelatedParties contextRef="eol_PE631979--1510-Q0001_STD_1_20150227_0_904377x1041555_904842x953825_907439x948370_907440x1092397" unitRef="iso4217_USD" decimals="-6" id="id_6193307_045E00AE-603A-4CAA-93D7-120B3D60B34E_1001_1">5000000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
  <us-gaap:AcquisitionCosts contextRef="eol_PE631979--1510-Q0001_STD_1_20150227_0_904377x1041555_904842x953825_907439x948370_907440x1092397" unitRef="iso4217_USD" decimals="-5" id="id_6193307_045E00AE-603A-4CAA-93D7-120B3D60B34E_1001_0">10700000</us-gaap:AcquisitionCosts>
  <mpw:NumberOfLeaseExtensionOptions contextRef="eol_PE631979--1510-Q0001_STD_1_20150227_0_904377x1041555_904842x953825_907439x948370_907440x1092397" unitRef="Leases" decimals="INF" id="id_6193307_045E00AE-603A-4CAA-93D7-120B3D60B34E_1001_4">3</mpw:NumberOfLeaseExtensionOptions>
  <mpw:LeaseRemainingTerm contextRef="eol_PE631979--1510-Q0001_STD_1_20150227_0_904377x1041555_904842x953825_907439x948370_907440x1092397" id="id_6193307_045E00AE-603A-4CAA-93D7-120B3D60B34E_1001_2">P17Y</mpw:LeaseRemainingTerm>
  <mpw:LeaseExtensionPeriod contextRef="eol_PE631979--1510-Q0001_STD_1_20150227_0_904377x1041555_904842x953825_907439x948370_907440x1092397" id="id_6193307_045E00AE-603A-4CAA-93D7-120B3D60B34E_1001_3">P5Y</mpw:LeaseExtensionPeriod>
  <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="eol_PE631979--1510-Q0001_STD_1_20120301_0" unitRef="iso4217_USD" decimals="-5" id="id_6193307_CC171053-2138-4DEA-8B37-91AF27184B83_1_0">1700000</us-gaap:DebtConversionConvertedInstrumentAmount1>
  <mpw:PercentageOfEquitySharesFromConvertibleDebt contextRef="eol_PE631979--1510-Q0001_STD_1_20120301_0" unitRef="pure" decimals="INF" id="id_6193307_CC171053-2138-4DEA-8B37-91AF27184B83_1_2">0.099</mpw:PercentageOfEquitySharesFromConvertibleDebt>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE631979--1510-Q0001_STD_1_20140311_0_907909x1068343" unitRef="iso4217_USD" decimals="-5" id="id_6193307_0BFB620C-010C-4BB5-A0AF-AE1A96F895BF_1001_1">100200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <mpw:UnderwritersPurchaseOfSharesToCoverOverAllotments contextRef="eol_PE631979--1510-Q0001_STD_1_20140311_0_907909x1068343" unitRef="shares" decimals="-5" id="id_6193307_0BFB620C-010C-4BB5-A0AF-AE1A96F895BF_1001_3">1200000</mpw:UnderwritersPurchaseOfSharesToCoverOverAllotments>
  <mpw:ProceedsFromAdditionalIssueOfShares contextRef="eol_PE631979--1510-Q0001_STD_1_20140311_0_907909x1068343" unitRef="iso4217_USD" decimals="-6" id="id_6193307_0BFB620C-010C-4BB5-A0AF-AE1A96F895BF_1001_4">16000000</mpw:ProceedsFromAdditionalIssueOfShares>
  <mpw:LeaseExpirationPeriod contextRef="eol_PE631979--1510-Q0001_STD_1_20150430_0_901032x907457_902887x904859_904377x1041555_907439x925328" id="id_6193307_B8FF687D-3FED-45E6-88C9-96687B3E01C6_1001_4">P60D</mpw:LeaseExpirationPeriod>
  <mpw:LeaseExpirationPeriod contextRef="eol_PE631979--1510-Q0001_STD_1_20150430_0_901032x909105_902887x904859_904377x1041555_907439x925328" id="id_6193307_B8FF687D-3FED-45E6-88C9-96687B3E01C6_2001_3">P30D</mpw:LeaseExpirationPeriod>
  <mpw:NumberOfHospitalsPurchasedAndLeased contextRef="eol_PE631979--1510-Q0001_STD_1_20150430_0_902887x904859_904377x1041555_907439x925328" unitRef="Hospital" decimals="INF" id="id_6193307_B8FF687D-3FED-45E6-88C9-96687B3E01C6_3001_2">31</mpw:NumberOfHospitalsPurchasedAndLeased>
  <us-gaap:LongTermPurchaseCommitmentAmount contextRef="eol_PE631979--1510-Q0001_STD_1_20150430_0_902887x904859_908505x1082625" unitRef="iso4217_USD" decimals="-6" id="id_6193307_354DE0EE-EAB2-43B3-914D-74B58D5A6438_1001_0">250000000</us-gaap:LongTermPurchaseCommitmentAmount>
  <mpw:NumberOfLeaseExtensionOptions contextRef="eol_PE631979--1510-Q0001_STD_1_20150430_0_902887x904859_908505x1082625" unitRef="Leases" decimals="INF" id="id_6193307_354DE0EE-EAB2-43B3-914D-74B58D5A6438_1001_3">3</mpw:NumberOfLeaseExtensionOptions>
  <mpw:LeaseAgreementIncreaseInConsumerPriceIndexFloorRateMinimum contextRef="eol_PE631979--1510-Q0001_STD_1_20150430_0_902887x904859_908505x1082625" unitRef="pure" decimals="INF" id="id_6193307_354DE0EE-EAB2-43B3-914D-74B58D5A6438_1001_4">0.02</mpw:LeaseAgreementIncreaseInConsumerPriceIndexFloorRateMinimum>
  <mpw:LeaseExtensionPeriod contextRef="eol_PE631979--1510-Q0001_STD_1_20150430_0_902887x904859_908505x1082625" id="id_6193307_354DE0EE-EAB2-43B3-914D-74B58D5A6438_1001_2">P5Y</mpw:LeaseExtensionPeriod>
  <mpw:LeaseAgreementTerm contextRef="eol_PE631979--1510-Q0001_STD_1_20150430_0_902887x904859_908505x1082625" id="id_6193307_354DE0EE-EAB2-43B3-914D-74B58D5A6438_1001_1">P15Y</mpw:LeaseAgreementTerm>
  <us-gaap:AcquisitionCosts contextRef="eol_PE631979--1510-Q0001_STD_1_20140331_0_904377x959676_907440x1082744" unitRef="iso4217_USD" decimals="-6" id="id_6193307_532C093B-1BE3-497A-9EAD-ED755A37029A_1001_0">115000000</us-gaap:AcquisitionCosts>
  <mpw:LeasePeriod contextRef="eol_PE631979--1510-Q0001_STD_1_20150331_0_904377x959676_907440x1082744" id="id_6193307_532C093B-1BE3-497A-9EAD-ED755A37029A_1002_1">P15Y</mpw:LeasePeriod>
  <mpw:LeaseExtensionPeriod contextRef="eol_PE631979--1510-Q0001_STD_1_20150331_0_904377x959676_907440x1082744" id="id_6193307_532C093B-1BE3-497A-9EAD-ED755A37029A_1002_2">P3Y</mpw:LeaseExtensionPeriod>
  <mpw:LeaseExtensionPeriod contextRef="eol_PE631979--1510-Q0001_STD_1_20150331_0_904377x959676_907440x1082744_910289x948168" id="id_6193307_532C093B-1BE3-497A-9EAD-ED755A37029A_2002_3">P12Y</mpw:LeaseExtensionPeriod>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE631979--1510-Q0001_STD_1_20150114_0_907909x1068343" unitRef="iso4217_USD" decimals="-6" id="id_6193307_FED8C849-CE97-4795-8F36-8327727D0B39_1001_3">480000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <mpw:UnderwritersPurchaseOfSharesToCoverOverAllotments contextRef="eol_PE631979--1510-Q0001_STD_1_20150114_0_907909x1068343" unitRef="shares" decimals="-5" id="id_6193307_FED8C849-CE97-4795-8F36-8327727D0B39_1001_2">4500000</mpw:UnderwritersPurchaseOfSharesToCoverOverAllotments>
  <mpw:SalesCommission contextRef="eol_PE631979--1510-Q0001_STD_31_20140131_0_907909x1026999" unitRef="pure" decimals="4" id="id_6193307_F519C380-3B89-42EC-9A48-D46B9613458B_1_1">0.0125</mpw:SalesCommission>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1510-Q0001_STD_365_20141231_0_903554x906990_907439x925328_908551x905169" unitRef="pure" decimals="3" id="id_6193307_095224FA-BB23-4CCC-8BFF-BEB1E7432E80_2002_1">0.113</us-gaap:ConcentrationRiskPercentage1>
  <mpw:PercentageOfAssetsLeased contextRef="eol_PE631979--1510-Q0001_STD_365_20141231_0_903554x906990_907439x937635" unitRef="pure" decimals="3" id="id_6193307_6042362D-31E0-43FC-B5E1-13FEDDAE3BA4_1003_1">0.126</mpw:PercentageOfAssetsLeased>
  <mpw:PercentageOfAssetsLoaned contextRef="eol_PE631979--1510-Q0001_STD_365_20141231_0_903554x906990_907439x937635" unitRef="pure" decimals="3" id="id_6193307_6042362D-31E0-43FC-B5E1-13FEDDAE3BA4_1003_2">0.074</mpw:PercentageOfAssetsLoaned>
  <mpw:PercentageOfAssetsLeased contextRef="eol_PE631979--1510-Q0001_STD_365_20141231_0_903554x906990_907439x948370" unitRef="pure" decimals="3" id="id_6193307_A94D596E-F2FB-4ABB-8EAB-DAD8D0119ADE_1003_2">0.077</mpw:PercentageOfAssetsLeased>
  <mpw:PercentageOfAssetsLoaned contextRef="eol_PE631979--1510-Q0001_STD_365_20141231_0_903554x906990_907439x948370" unitRef="pure" decimals="3" id="id_6193307_A94D596E-F2FB-4ABB-8EAB-DAD8D0119ADE_1003_3">0.053</mpw:PercentageOfAssetsLoaned>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1510-Q0001_STD_365_20141231_0_903554x907273_904842x902145_908551x905169" unitRef="pure" decimals="2" id="id_6193307_16DECFE3-A282-4067-9BBE-72D33EF424B9_1002_2">0.20</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1510-Q0001_STD_365_20141231_0_903554x907273_904842x906342_908551x905169" unitRef="pure" decimals="3" id="id_6193307_98D65352-28ED-40EA-9D81-CA81E8528885_1002_0">0.146</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1510-Q0001_STD_365_20141231_0_903554x907273_904842x906348_908551x905169" unitRef="pure" decimals="3" id="id_6193307_98D65352-28ED-40EA-9D81-CA81E8528885_2002_1">0.202</us-gaap:ConcentrationRiskPercentage1>
  <mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime contextRef="eol_PE631979--1510-Q0001_STD_365_20141231_0_910720x1049647" id="id_6193307_5EAC5479-4C0D-4410-BFF1-F5BC062D19CC_1002_7">Various</mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime>
  <mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime contextRef="eol_PE631979--1510-Q0001_STD_365_20141231_0_910720x901310" id="id_6193307_5EAC5479-4C0D-4410-BFF1-F5BC062D19CC_2002_1">Various</mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime>
  <mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime contextRef="eol_PE631979--1510-Q0001_STD_365_20141231_0_910720x912276" id="id_6193307_5EAC5479-4C0D-4410-BFF1-F5BC062D19CC_3002_0">Variable</mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_33">0.04</us-gaap:EarningsPerShareDiluted>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="shares" decimals="-3" id="id_6193307_8FF78180-9D59-46F0-9398-291DBB99DDC4_2_7">576000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_14">18282000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_31">0.04</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD_per_shares" decimals="0" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_27">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="shares" decimals="-3" id="id_6193307_8FF78180-9D59-46F0-9398-291DBB99DDC4_2_8">164549000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_28">0.04</us-gaap:EarningsPerShareBasic>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_26">0.04</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:CommonStockDividendsPerShareDeclared contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_35">0.21</us-gaap:CommonStockDividendsPerShareDeclared>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD_per_shares" decimals="0" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_32">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="shares" decimals="-3" id="id_6193307_8FF78180-9D59-46F0-9398-291DBB99DDC4_2_6">163973000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:PaymentsOfOrdinaryDividends contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_24">35778000</us-gaap:PaymentsOfOrdinaryDividends>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_23">68000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:PaymentsToAcquireLoansReceivable contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_18">2385000</us-gaap:PaymentsToAcquireLoansReceivable>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8FF78180-9D59-46F0-9398-291DBB99DDC4_2_4">-2000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
  <us-gaap:ProfitLoss contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_22">7307000</us-gaap:ProfitLoss>
  <us-gaap:StraightLineRent contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_2">2148000</us-gaap:StraightLineRent>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_13">28694000</us-gaap:OperatingIncomeLoss>
  <us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_4">15769000</us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EB48F6C1-A97A-4316-B60F-4F3FDD06C0CC_2_6">7934000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_19">-21385000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_21">-2000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:PaymentsToAcquireRealEstate contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_16">115000000</us-gaap:PaymentsToAcquireRealEstate>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_15">-50000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EB48F6C1-A97A-4316-B60F-4F3FDD06C0CC_2_2">721000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EB48F6C1-A97A-4316-B60F-4F3FDD06C0CC_2_3">-28000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_3">12215000</us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue>
  <us-gaap:Revenues contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_5">73089000</us-gaap:Revenues>
  <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_10">-1239000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:NetIncomeLoss contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_24">7241000</us-gaap:NetIncomeLoss>
  <us-gaap:InterestPaid contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_33">22613000</us-gaap:InterestPaid>
  <us-gaap:OtherNonoperatingIncome contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_16">220000</us-gaap:OtherNonoperatingIncome>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8FF78180-9D59-46F0-9398-291DBB99DDC4_2_0">7309000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EB48F6C1-A97A-4316-B60F-4F3FDD06C0CC_2_4">8000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:AssetImpairmentCharges contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_8">20496000</us-gaap:AssetImpairmentCharges>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_3">13972000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:InterestExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_17">21612000</us-gaap:InterestExpense>
  <us-gaap:ProceedsFromCollectionOfLoansReceivable contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_17">1469000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_9">1049000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:EffectOfExchangeRateOnCash contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_30">13000</us-gaap:EffectOfExchangeRateOnCash>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_29">4317000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_18">-57000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_20">-143841000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_7">13690000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_9">738000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_25">112583000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_27">-241000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_28">129876000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_11">512000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:CostsAndExpenses contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_12">44395000</us-gaap:CostsAndExpenses>
  <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8FF78180-9D59-46F0-9398-291DBB99DDC4_2_1">66000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_10">8959000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_13">-19641000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_23">66000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_8">2287000</us-gaap:ShareBasedCompensation>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EB48F6C1-A97A-4316-B60F-4F3FDD06C0CC_2_5">66000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <us-gaap:ImpairmentOfRealEstate contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_6">950000</us-gaap:ImpairmentOfRealEstate>
  <mpw:ProceedsFromLeaseDepositsAndOtherObligationsToTenants contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_26">3380000</mpw:ProceedsFromLeaseDepositsAndOtherObligationsToTenants>
  <mpw:RevolvingCreditFacilitiesNet contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_22">-50000000</mpw:RevolvingCreditFacilitiesNet>
  <mpw:ConstructionInProgressEquipmentAndOther contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_19">27925000</mpw:ConstructionInProgressEquipmentAndOther>
  <mpw:StraightLineRentRevenue contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_5">3099000</mpw:StraightLineRentRevenue>
  <mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8FF78180-9D59-46F0-9398-291DBB99DDC4_2_3">7034000</mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings>
  <mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8FF78180-9D59-46F0-9398-291DBB99DDC4_2_5">7032000</mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings>
  <mpw:RentBilled contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_2_1">42957000</mpw:RentBilled>
  <mpw:IncreaseDecreaseInInterestAndRentReceivable contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_12">4674000</mpw:IncreaseDecreaseInInterestAndRentReceivable>
  <mpw:RecognitionOfUnearnedIncomeOnDirectFinancingAndSalesTypeLeases contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_2_4">1604000</mpw:RecognitionOfUnearnedIncomeOnDirectFinancingAndSalesTypeLeases>
  <mpw:UndistributedEarningAllocatedToParticipatingSecurities contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8FF78180-9D59-46F0-9398-291DBB99DDC4_2_2">209000</mpw:UndistributedEarningAllocatedToParticipatingSecurities>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_901822x1064668" unitRef="shares" decimals="INF" id="id_6193307_BE583270-B49A-4FDE-98C3-63FB27A943CC_1002_0">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_901822x905956" unitRef="shares" decimals="INF" id="id_6193307_76B51B2D-B01A-4E77-B90B-A4F5337F8D02_1002_0">317254</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_901822x992702" unitRef="shares" decimals="INF" id="id_6193307_7DF499F2-12C8-46BD-9DB8-499AB3145CAA_1002_0">338484</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_903554x906990_907439x937635_908551x904419" unitRef="pure" decimals="3" id="id_6193307_6042362D-31E0-43FC-B5E1-13FEDDAE3BA4_2002_0">0.291</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_903554x906990_907439x948370_908551x904419" unitRef="pure" decimals="3" id="id_6193307_A94D596E-F2FB-4ABB-8EAB-DAD8D0119ADE_2002_0">0.196</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:Revenues contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_904842x902145" unitRef="iso4217_USD" decimals="-5" id="id_6193307_16DECFE3-A282-4067-9BBE-72D33EF424B9_3003_1">5500000</us-gaap:Revenues>
  <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_907645x976566" id="id_6193307_607196C8-8F0B-49C3-BE09-20BB3032BDE8_1002_3">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_907676x1295251" unitRef="iso4217_USD" decimals="-6" id="id_6193307_FA818C7A-7A7B-4C76-A061-35191336ED1C_1002_0">1000000</us-gaap:AmortizationOfIntangibleAssets>
  <mpw:StraightLineRentReceivablesWriteOff contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_907676x1295251" unitRef="iso4217_USD" decimals="-5" id="id_6193307_FA818C7A-7A7B-4C76-A061-35191336ED1C_1002_2">1100000</mpw:StraightLineRentReceivablesWriteOff>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_907909x1026999" unitRef="iso4217_USD" decimals="-5" id="id_6193307_F519C380-3B89-42EC-9A48-D46B9613458B_2_4">12300000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_910288x904022" unitRef="iso4217_USD" decimals="INF" id="id_6193307_5CE2832B-8ADB-4508-83D3-CECBD7CC8610_1002_0">0</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD_per_shares" decimals="2" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_33">0.04</us-gaap:EarningsPerShareDiluted>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_E1EF175D-A3DC-4F93-A771-301E2AFC2806_1002_7">576000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_14">18282000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD_per_shares" decimals="2" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_31">0.04</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD_per_shares" decimals="0" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_27">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_E1EF175D-A3DC-4F93-A771-301E2AFC2806_1002_8">164549000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD_per_shares" decimals="2" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_28">0.04</us-gaap:EarningsPerShareBasic>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD_per_shares" decimals="2" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_26">0.04</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:PartnersCapitalAccountUnitsSaleOfUnits contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="shares" decimals="-5" id="id_6193307_521DB8E0-9F6D-49E8-9A0A-0EFF0FDDA678_3002_1">8600000</us-gaap:PartnersCapitalAccountUnitsSaleOfUnits>
  <us-gaap:CommonStockDividendsPerShareDeclared contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_35">0.21</us-gaap:CommonStockDividendsPerShareDeclared>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD_per_shares" decimals="0" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_32">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_E1EF175D-A3DC-4F93-A771-301E2AFC2806_1002_6">163973000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:PaymentsOfOrdinaryDividends contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_24">35778000</us-gaap:PaymentsOfOrdinaryDividends>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_23">68000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:PaymentsToAcquireLoansReceivable contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_18">2385000</us-gaap:PaymentsToAcquireLoansReceivable>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_E1EF175D-A3DC-4F93-A771-301E2AFC2806_1002_4">-2000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
  <us-gaap:ProfitLoss contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_22">7307000</us-gaap:ProfitLoss>
  <us-gaap:StraightLineRent contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_2">2148000</us-gaap:StraightLineRent>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_13">28694000</us-gaap:OperatingIncomeLoss>
  <us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_4">15769000</us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_9AA113F4-E16A-4379-A90D-F5B1583DA9A0_1002_6">7934000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_19">-21385000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_21">-2000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
  <us-gaap:PaymentsToAcquireRealEstate contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_16">115000000</us-gaap:PaymentsToAcquireRealEstate>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_15">-50000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_9AA113F4-E16A-4379-A90D-F5B1583DA9A0_1002_2">721000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_9AA113F4-E16A-4379-A90D-F5B1583DA9A0_1002_3">-28000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_3">12215000</us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue>
  <us-gaap:Revenues contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_5">73089000</us-gaap:Revenues>
  <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_10">-1239000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:NetIncomeLoss contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_24">7241000</us-gaap:NetIncomeLoss>
  <us-gaap:InterestPaid contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_33">22613000</us-gaap:InterestPaid>
  <us-gaap:OtherNonoperatingIncome contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_16">220000</us-gaap:OtherNonoperatingIncome>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_E1EF175D-A3DC-4F93-A771-301E2AFC2806_1002_0">7309000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_9AA113F4-E16A-4379-A90D-F5B1583DA9A0_1002_4">8000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:AssetImpairmentCharges contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_8">20496000</us-gaap:AssetImpairmentCharges>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_3">13972000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:InterestExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_17">21612000</us-gaap:InterestExpense>
  <us-gaap:ProceedsFromCollectionOfLoansReceivable contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_17">1469000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_9">1049000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:EffectOfExchangeRateOnCash contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_30">13000</us-gaap:EffectOfExchangeRateOnCash>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_29">4317000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_18">-57000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_20">-143841000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_7">13690000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_9">738000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_25">112583000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_27">-241000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_28">129876000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_11">512000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:CostsAndExpenses contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_12">44395000</us-gaap:CostsAndExpenses>
  <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_E1EF175D-A3DC-4F93-A771-301E2AFC2806_1002_1">66000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_10">8959000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_13">-19641000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_23">66000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_8">2287000</us-gaap:ShareBasedCompensation>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_9AA113F4-E16A-4379-A90D-F5B1583DA9A0_1002_5">66000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <us-gaap:ImpairmentOfRealEstate contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_6">950000</us-gaap:ImpairmentOfRealEstate>
  <mpw:ProceedsFromLeaseDepositsAndOtherObligationsToTenants contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_26">3380000</mpw:ProceedsFromLeaseDepositsAndOtherObligationsToTenants>
  <mpw:RevolvingCreditFacilitiesNet contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_22">-50000000</mpw:RevolvingCreditFacilitiesNet>
  <mpw:ConstructionInProgressEquipmentAndOther contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_19">27925000</mpw:ConstructionInProgressEquipmentAndOther>
  <mpw:StraightLineRentRevenue contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_5">3099000</mpw:StraightLineRentRevenue>
  <mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_E1EF175D-A3DC-4F93-A771-301E2AFC2806_1002_3">7034000</mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings>
  <mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_E1EF175D-A3DC-4F93-A771-301E2AFC2806_1002_5">7032000</mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings>
  <mpw:RentBilled contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1002_1">42957000</mpw:RentBilled>
  <mpw:IncreaseDecreaseInInterestAndRentReceivable contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_12">4674000</mpw:IncreaseDecreaseInInterestAndRentReceivable>
  <mpw:RecognitionOfUnearnedIncomeOnDirectFinancingAndSalesTypeLeases contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1002_4">1604000</mpw:RecognitionOfUnearnedIncomeOnDirectFinancingAndSalesTypeLeases>
  <mpw:UndistributedEarningAllocatedToParticipatingSecurities contextRef="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_E1EF175D-A3DC-4F93-A771-301E2AFC2806_1002_2">209000</mpw:UndistributedEarningAllocatedToParticipatingSecurities>
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_963FB307-C819-4B1D-940E-0538D32FA2DE_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;9. Contingencies&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 We are a party to various legal proceedings incidental to our
 business. In the opinion of management, after consultation with
 legal counsel, the ultimate liability, if any, with respect to
 those proceedings is not presently expected to materially affect
 our financial position, results of operations or cash flows.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_33">0.17</us-gaap:EarningsPerShareDiluted>
  <us-gaap:EarningsPerShareTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_66ACEE8B-928B-46C8-AFF7-5BED79E277F2_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;8. Earnings Per Share&lt;/b&gt;&lt;/p&gt;
 &lt;!-- xbrl,body --&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;i&gt;Medical Properties Trust, Inc.&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Our earnings per share were calculated based on the following
 (amounts in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;&lt;!-- Begin Table Head --&gt;
 &lt;tr&gt;
 &lt;td width="77%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;For&amp;#xA0;the&amp;#xA0;Three Months&lt;br /&gt;
 Ended&amp;#xA0;March 31,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Head --&gt;&lt;!-- Begin Table Body --&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Numerator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Income from continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;35,976&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,309&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Non-controlling interests&amp;#x2019; share in continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(79&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(66&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Participating securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(266&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(209&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;
 Income from continuing operations, less participating
 securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;35,631&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,034&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;
 Income (loss) from discontinued operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;
 Net income, less participating securities&amp;#x2019; share in
 earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;35,631&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,032&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Denominator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Basic weighted-average common shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;202,958&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;163,973&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Dilutive potential common shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;657&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;576&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;
 Dilutive weighted-average common shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;203,615&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;164,549&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Body --&gt;&lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;i&gt;MPT Operating Partnership, L.P.&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 Our earnings per common unit were calculated based on the following
 (amounts in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;&lt;!-- Begin Table Head --&gt;
 &lt;tr&gt;
 &lt;td width="77%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;For the Three Months&lt;br /&gt;
 Ended March 31,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Head --&gt;&lt;!-- Begin Table Body --&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Numerator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Income from continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;35,976&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,309&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Non-controlling interests&amp;#x2019; share in continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(79&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(66&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Participating securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(266&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(209&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;
 Income from continuing operations, less participating
 securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;35,631&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,034&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;
 Income (loss) from discontinued operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;
 Net income, less participating securities&amp;#x2019; share in
 earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;35,631&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,032&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Denominator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Basic weighted-average units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;202,958&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;163,973&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Dilutive potential units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;657&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;576&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Diluted weighted-average units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;203,615&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;164,549&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_C5AB010F-B535-44FB-AE76-6B91745A4F16_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 At March&amp;#xA0;31, 2015, these amounts were as follows (in
 thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="63%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 37.55pt"&gt;
 &lt;b&gt;Asset Type&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Fair&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center"&gt;&lt;b&gt;Asset&amp;#xA0;Type&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;Classification&lt;/b&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Mortgage loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;100,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;100,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;Mortgage&amp;#xA0;loans&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Acquisition loan&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;102,450&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;102,450&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;Other&amp;#xA0;loans&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Equity investments&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,300&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,300&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;Other&amp;#xA0;assets&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;205,750&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;205,750&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
  <dei:DocumentType contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_5971E97C-1419-4316-8F57-7E149560F042_1_0">10-Q</dei:DocumentType>
  <dei:EntityRegistrantName contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_6A94DFD6-FD91-454D-B669-5B289045196E_1_1">MEDICAL PROPERTIES TRUST INC.</dei:EntityRegistrantName>
  <dei:TradingSymbol contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_6A94DFD6-FD91-454D-B669-5B289045196E_1_0">MPW</dei:TradingSymbol>
  <us-gaap:FairValueInputsDiscountRate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="pure" decimals="2" id="id_6193307_440F3A2E-AC52-47E3-9909-0F894C9DAB7B_1_0">0.40</us-gaap:FairValueInputsDiscountRate>
  <dei:EntityFilerCategory contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_6A94DFD6-FD91-454D-B669-5B289045196E_1_4">Large Accelerated Filer</dei:EntityFilerCategory>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="shares" decimals="-3" id="id_6193307_8FF78180-9D59-46F0-9398-291DBB99DDC4_1_7">657000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_14">42026000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_31">0.17</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <us-gaap:PartnersCapitalNotesDisclosureTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_69984C82-BD0D-4C4A-AF9A-D2BF52F5A168_1_0">&lt;div&gt;
 &lt;p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;5. Common Stock/Partner&amp;#x2019;s Capital&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;i&gt;Medical Properties Trust, Inc.&lt;/i&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"&gt;
 On January&amp;#xA0;14, 2015, we completed an underwritten public
 offering of 34.5&amp;#xA0;million shares (including the exercise of the
 underwriters&amp;#x2019; 30-day option to purchase an additional
 4.5&amp;#xA0;million shares) of our common stock, resulting in net
 proceeds of approximately $480 million, after deducting estimated
 offering expenses.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"&gt;
 On March&amp;#xA0;11, 2014, we completed an underwritten public
 offering of 7.7&amp;#xA0;million shares of our common stock, resulting
 in net proceeds of approximately $100.2 million, after deducting
 estimated offering expenses. We also granted the underwriters a
 30-day option to purchase up to an additional 1.2&amp;#xA0;million
 shares of common stock. The option, which was exercised in full,
 closed on April&amp;#xA0;8, 2014 and resulted in additional net
 proceeds of approximately $16 million.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"&gt;
 In January 2014, we put an at-the-market equity offering program in
 place, giving us the ability to sell up to $250 million of stock
 with a commission of 1.25%. During the 2014 first quarter, we sold
 0.9&amp;#xA0;million shares of our common stock under our at-the-market
 equity offering program, at an average price of $13.21 per share
 resulting in total proceeds, net of commission, of $12.3 million.
 There were no shares issued under the at-the-market equity offering
 program during the 2015 first quarter.&lt;/p&gt;
 &lt;p style="font-size:1px;margin-top:18px;margin-bottom:0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;i&gt;MPT Operating Partnership, L.P.&lt;/i&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"&gt;
 At March&amp;#xA0;31, 2015, the Company has a 99.8% ownership interest
 in the Operating Partnership with the remainder owned by three
 other partners, two of whom are employees and one of whom is a
 director. During the three months ended March&amp;#xA0;31, 2015 and
 2014, the partnership issued 34.5&amp;#xA0;million and 8.6&amp;#xA0;million
 units, respectively, in direct response to the common stock
 offerings by Medical Properties Trust, Inc.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:PartnersCapitalNotesDisclosureTextBlock>
  <dei:DocumentPeriodEndDate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_5971E97C-1419-4316-8F57-7E149560F042_1_2">2015-03-31</dei:DocumentPeriodEndDate>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD_per_shares" decimals="0" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_27">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <dei:AmendmentFlag contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_5971E97C-1419-4316-8F57-7E149560F042_1_1">false</dei:AmendmentFlag>
  <dei:CurrentFiscalYearEndDate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_6A94DFD6-FD91-454D-B669-5B289045196E_1_3">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentFiscalYearFocus contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_5971E97C-1419-4316-8F57-7E149560F042_1_3">2015</dei:DocumentFiscalYearFocus>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="shares" decimals="-3" id="id_6193307_8FF78180-9D59-46F0-9398-291DBB99DDC4_1_8">203615000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:ConsolidationPolicyTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_402AA365-7CF4-49E2-9409-C28525B37623_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 &lt;i&gt;Unaudited Interim Condensed Consolidated Financial
 Statements&lt;/i&gt;: The accompanying unaudited interim condensed
 consolidated financial statements have been prepared in accordance
 with accounting principles generally accepted in the United States
 for interim financial information, including rules and regulations
 of the Securities and Exchange Commission. Accordingly, they do not
 include all of the information and footnotes required by generally
 accepted accounting principles (&amp;#x201C;GAAP&amp;#x201D;) for complete
 financial statements. In the opinion of management, all adjustments
 (consisting of normal recurring accruals) considered necessary for
 a fair presentation have been included. Operating results for the
 three month period ended March&amp;#xA0;31, 2015, are not necessarily
 indicative of the results that may be expected for the year ending
 December&amp;#xA0;31, 2015. The condensed consolidated balance sheet at
 December&amp;#xA0;31, 2014 has been derived from the audited financial
 statements at that date but does not include all of the information
 and footnotes required by accounting principles generally accepted
 in the United States for complete financial statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 For information about significant accounting policies, refer to the
 consolidated financial statements and footnotes thereto included in
 our Annual Report on Form 10-K for the year ended December&amp;#xA0;31,
 2014. During the three months ended March&amp;#xA0;31, 2015, there were
 no material changes to these policies.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_28">0.18</us-gaap:EarningsPerShareBasic>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD_per_shares" decimals="2" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_26">0.18</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:LongTermDebtTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_3B935F14-8770-428E-AE8C-1A71C84DDC84_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;b&gt;4. Debt&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 The following is a summary of debt, net of discounts (dollar
 amounts in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="56%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&amp;#xA0;March&amp;#xA0;31,
 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&amp;#xA0;December&amp;#xA0;31,
 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Balance&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Interest&amp;#xA0;Rate&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Balance&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Interest&amp;#xA0;Rate&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Revolving credit facility&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;301,655&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Variable&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;593,490&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Variable&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2006 Senior Unsecured Notes&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;125,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;125,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2011 Senior Unsecured Notes&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;450,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.875%&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;450,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.875%&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2012 Senior Unsecured Notes:&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Principal amount&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;350,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.375%&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;350,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.375%&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Unamortized premium&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,433&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,522&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;352,433&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;352,522&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1pt"&gt;
 &lt;td height="8"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="4"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="4"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="4"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="4"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2013 Senior Unsecured Notes (A)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;214,620&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.750%&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;241,960&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.750%&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2014 Senior Unsecured Notes&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;300,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.500%&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;300,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.500%&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Term loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;138,611&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;138,682&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,882,319&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,201,654&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(A)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;These notes are Euro-denominated and
 reflect the exchange rate at March&amp;#xA0;31, 2015 and
 December&amp;#xA0;31, 2014, respectively.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 As of March&amp;#xA0;31, 2015, principal payments due on our debt
 (which exclude the effects of any discounts or premiums recorded)
 are as follows (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="85%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2015&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;211&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2016&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;125,299&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2017&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;320&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2018&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;314,436&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2019&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;125,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Thereafter&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,314,620&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Total&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,879,886&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 During the second quarter 2010, we entered into an interest rate
 swap to manage our exposure to variable interest rates by fixing
 $65 million of our 2006 Senior Unsecured Notes, which started
 July&amp;#xA0;31, 2011 (date on which the interest rate turned
 variable) through maturity date (or July 2016), at a rate of
 5.507%. We also entered into an interest rate swap to fix $60
 million of our 2006 Senior Unsecured Notes which started
 October&amp;#xA0;31, 2011 (date on which the related interest rate
 turned variable) through the maturity date (or October 2016) at a
 rate of 5.675%. The fair value of the interest rate swaps was $5.5
 million and $6.0 million as of March&amp;#xA0;31, 2015 and
 December&amp;#xA0;31, 2014, respectively, which is reflected in
 accounts payable and accrued expenses on the consolidated balance
 sheets.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 We account for our interest rate swaps as cash flow hedges.
 Accordingly, the effective portion of changes in the fair value of
 our swaps is recorded as a component of accumulated other
 comprehensive income/loss on the balance sheet and reclassified
 into earnings in the same period, or periods, during which the
 hedged transactions effect earnings, while any ineffective portion
 is recorded through earnings immediately. We did not have any hedge
 ineffectiveness from inception of our interest rate swaps through
 March&amp;#xA0;31, 2015 and therefore, there was no income statement
 effect recorded during the three month periods ended March&amp;#xA0;31,
 2015 or 2014. We do not expect any of the current losses included
 in accumulated other comprehensive loss to be reclassified into
 earnings in the next 12 months. At March&amp;#xA0;31, 2015 and
 December&amp;#xA0;31, 2014, we have posted $2.8 million and $3.3
 million of collateral related to our interest rate swaps,
 respectively, which is reflected in other assets on our
 consolidated balance sheets.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Covenants&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 Our debt facilities impose certain restrictions on us, including
 restrictions on our ability to: incur debts; create or incur liens;
 provide guarantees in respect of obligations of any other entity;
 make redemptions and repurchases of our capital stock; prepay,
 redeem or repurchase debt; engage in mergers or consolidations;
 enter into affiliated transactions; dispose of real estate or other
 assets; and change our business. In addition, the credit agreements
 governing our revolving credit facility and term loan limit the
 amount of dividends we can pay as a percentage of normalized
 adjusted funds from operations, as defined in the agreements, on a
 rolling four quarter basis. At March&amp;#xA0;31, 2015, the dividend
 restriction was 95% of normalized adjusted FFO. The indentures
 governing our senior unsecured notes also limit the amount of
 dividends we can pay based on the sum of 95% of funds from
 operations, proceeds of equity issuances and certain other net cash
 proceeds. Finally, our senior unsecured notes require us to
 maintain total unencumbered assets (as defined in the related
 indenture) of not less than 150% of our unsecured indebtedness.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 In addition to these restrictions, the revolving credit facility
 and term loan contain customary financial and operating covenants,
 including covenants relating to our total leverage ratio, fixed
 charge coverage ratio, mortgage secured leverage ratio, recourse
 mortgage secured leverage ratio, consolidated adjusted net worth,
 facility leverage ratio, and unsecured interest coverage ratio.
 This facility also contains customary events of default, including
 among others, nonpayment of principal or interest, material
 inaccuracy of representations and failure to comply with our
 covenants. If an event of default occurs and is continuing under
 the facility, the entire outstanding balance may become immediately
 due and payable. At March&amp;#xA0;31, 2015, we were in compliance with
 all such financial and operating covenants.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_1AAA55BA-DA3B-438A-B0EB-FD5F2B8DB153_1_0">&lt;div&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;
 &lt;b&gt;1. Organization&lt;/b&gt;&lt;/p&gt;
 &lt;p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"&gt;
 Medical Properties Trust, Inc., a Maryland corporation, was formed
 on August&amp;#xA0;27, 2003, under the Maryland General Corporation Law
 for the purpose of engaging in the business of investing in,
 owning, and leasing commercial real estate. Our operating
 partnership subsidiary, MPT Operating Partnership, L.P., (the
 &amp;#x201C;Operating Partnership&amp;#x201D;) through which we conduct all
 of our operations, was formed in September 2003. Through another
 wholly-owned subsidiary, Medical Properties Trust, LLC, we are the
 sole general partner of the Operating Partnership. At present, we
 directly own substantially all of the limited partnership interests
 in the Operating Partnership and have elected to report our
 required disclosures and that of the Operating Partnership on a
 combined basis except where material differences exist.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"&gt;
 We have operated as a real estate investment trust
 (&amp;#x201C;REIT&amp;#x201D;) since April&amp;#xA0;6, 2004, and accordingly,
 elected REIT status upon the filing in September 2005 of the
 calendar year 2004 federal income tax return. Accordingly, we will
 generally not be subject to U.S. federal income tax, provided that
 we continue to qualify as a REIT and our distributions to our
 stockholders equal or exceed our taxable income. Certain activites
 we undertake must be conducted by entities which we elected to be
 treated as taxable REIT subsidiaries (&amp;#x201C;TRSs&amp;#x201D;). Our TRSs
 are subject to both U.S. federal and state income taxes.&lt;/p&gt;
 &lt;p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"&gt;
 Our primary business strategy is to acquire and develop real estate
 and improvements, primarily for long-term lease to providers of
 healthcare services such as operators of general acute care
 hospitals, inpatient physical rehabilitation hospitals, long-term
 acute care hospitals, surgery centers, centers for treatment of
 specific conditions such as cardiac, pulmonary, cancer, and
 neurological hospitals, and other healthcare-oriented facilities.
 We also make mortgage and other loans to operators of similar
 facilities. In addition, we may obtain profits or equity interests
 in our tenants, from time to time, in order to enhance our overall
 return. We manage our business as a single business segment. All of
 our properties are located in the United States and Europe.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_2D961EC7-9151-4572-B22B-169916E89CE0_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;i&gt;Medical Properties Trust, Inc.&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 Our earnings per share were calculated based on the following
 (amounts in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;&lt;!-- Begin Table Head --&gt;
 &lt;tr&gt;
 &lt;td width="77%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;For&amp;#xA0;the&amp;#xA0;Three Months&lt;br /&gt;
 Ended&amp;#xA0;March 31,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Head --&gt;&lt;!-- Begin Table Body --&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Numerator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Income from continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;35,976&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,309&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Non-controlling interests&amp;#x2019; share in continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(79&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(66&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Participating securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(266&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(209&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;
 Income from continuing operations, less participating
 securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;35,631&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,034&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;
 Income (loss) from discontinued operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;
 Net income, less participating securities&amp;#x2019; share in
 earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;35,631&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,032&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Denominator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Basic weighted-average common shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;202,958&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;163,973&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Dilutive potential common shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;657&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;576&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;
 Dilutive weighted-average common shares&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;203,615&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;164,549&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Body --&gt;&lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;i&gt;MPT Operating Partnership, L.P.&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 Our earnings per common unit were calculated based on the following
 (amounts in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;&lt;!-- Begin Table Head --&gt;
 &lt;tr&gt;
 &lt;td width="77%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;For the Three Months&lt;br /&gt;
 Ended March 31,&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Head --&gt;&lt;!-- Begin Table Body --&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Numerator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Income from continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;35,976&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,309&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Non-controlling interests&amp;#x2019; share in continuing operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(79&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(66&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Participating securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(266&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(209&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;
 Income from continuing operations, less participating
 securities&amp;#x2019; share in earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;35,631&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,034&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;
 Income (loss) from discontinued operations&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 5em; TEXT-INDENT: -1em"&gt;
 Net income, less participating securities&amp;#x2019; share in
 earnings&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;35,631&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;7,032&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Denominator:&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Basic weighted-average units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;202,958&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;163,973&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Dilutive potential units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;657&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;576&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Diluted weighted-average units&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;203,615&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;164,549&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;


 &lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_BE8FCBF5-6B31-4622-9728-DFE533F8E749_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;2. Summary of Significant Accounting Policies&lt;/b&gt;&lt;/p&gt;
 &lt;!-- xbrl,body --&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 &lt;i&gt;Unaudited Interim Condensed Consolidated Financial
 Statements&lt;/i&gt;: The accompanying unaudited interim condensed
 consolidated financial statements have been prepared in accordance
 with accounting principles generally accepted in the United States
 for interim financial information, including rules and regulations
 of the Securities and Exchange Commission. Accordingly, they do not
 include all of the information and footnotes required by generally
 accepted accounting principles (&amp;#x201C;GAAP&amp;#x201D;) for complete
 financial statements. In the opinion of management, all adjustments
 (consisting of normal recurring accruals) considered necessary for
 a fair presentation have been included. Operating results for the
 three month period ended March&amp;#xA0;31, 2015, are not necessarily
 indicative of the results that may be expected for the year ending
 December&amp;#xA0;31, 2015. The condensed consolidated balance sheet at
 December&amp;#xA0;31, 2014 has been derived from the audited financial
 statements at that date but does not include all of the information
 and footnotes required by accounting principles generally accepted
 in the United States for complete financial statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 For information about significant accounting policies, refer to the
 consolidated financial statements and footnotes thereto included in
 our Annual Report on Form 10-K for the year ended December&amp;#xA0;31,
 2014. During the three months ended March&amp;#xA0;31, 2015, there were
 no material changes to these policies.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 18pt"&gt;
 &lt;i&gt;Recent Accounting Developments:&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 8%"&gt;
 &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 In May 2014, the Financial Accounting Standards Board
 (&amp;#x201C;FASB&amp;#x201D;) issued Accounting Standards Update
 (&amp;#x201C;ASU&amp;#x201D;) No.&amp;#xA0;2014-09, &amp;#x201C;Revenue from Contracts
 with Customers.&amp;#x201D; Under the new standard, revenue is
 recognized at the time a good or service is transferred to a
 customer for the amount of consideration received for that specific
 good or service.&amp;#xA0;Entities may use a full retrospective
 approach or report the cumulative effect as of the date of
 adoption.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 On April&amp;#xA0;1, 2015, the FASB proposed deferring the effective
 date by one year to December&amp;#xA0;15, 2017, for annual reporting
 periods beginning after that date. The FASB also proposed
 permitting early adoption of the standard, but not before the
 original effective date of December&amp;#xA0;15, 2016. We are currently
 evaluating the impact, if any, the adoption of this standard will
 have on our consolidated financial statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 18px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 8%"&gt;
 &lt;i&gt;Presentation of Debt Issuance Costs&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 In April 2015, the FASB issued ASU No.&amp;#xA0;2015-03,
 &amp;#x201C;Simplifying the Presentation of Debt Issuance Costs.&amp;#x201D;
 This standard amends existing guidance to require the presentation
 of debt issuance costs in the balance sheet as a deduction from the
 carrying amount of the related debt liability instead of a deferred
 charge. It is effective for annual reporting periods beginning
 after December&amp;#xA0;15, 2015, but early adoption is permitted.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt; TEXT-INDENT: 8%"&gt;
 &lt;i&gt;Amendments to the Consolidation Analysis&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 In February 2015, the FASB issued an ASU 2015-02 that modifies the
 evaluation of whether limited partnerships and similar legal
 entities are VIEs, eliminates the presumption that a general
 partner should consolidate a limited partnership and affects the
 consolidation analysis of reporting entities that are involved with
 VIEs, particularly those that have fee arrangements and related
 party relationships. The guidance is effective for fiscal years
 beginning after December 15, 2015, but early adoption is
 permitted.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt; TEXT-INDENT: 4%"&gt;
 &lt;i&gt;Variable Interest Entities&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 At March&amp;#xA0;31, 2015, we had loans to and/or equity investments
 in certain variable interest entities (&amp;#x201C;VIEs&amp;#x201D;), which
 are also tenants of our facilities, including Ernest. We have
 determined that we are not the primary beneficiary of these VIEs.
 The carrying value and classification of the related assets and
 maximum exposure to loss as a result of our involvement with these
 VIEs are presented below at March&amp;#xA0;31, 2015 (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;&lt;!-- Begin Table Head --&gt;
 &lt;tr&gt;
 &lt;td width="51%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 33.6pt"&gt;
 &lt;b&gt;VIE Type&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Maximum&amp;#xA0;Loss&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;Exposure(1)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center"&gt;&lt;b&gt;Asset&amp;#xA0;Type&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;Classification&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 Amount(2)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Head --&gt;&lt;!-- Begin Table Body --&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Loans, net&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;264,397&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;
 Mortgage&amp;#xA0;and&amp;#xA0;other&amp;#xA0;loans&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;
 &amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;212,196&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Equity investments&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;59,228&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;Other&amp;#xA0;assets&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,324&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Body --&gt;&lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(1)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Our maximum loss exposure related to
 loans with VIEs represents our current aggregate gross carrying
 value of the loan plus accrued interest and any other related
 assets (such as rents receivable), less any liabilities. Our
 maximum loss exposure related to our equity investment in VIEs
 represents the current carrying values of such investment plus any
 other related assets (such as rent receivables) less any
 liabilities.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(2)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Carrying amount reflects the net book
 value of our loan or equity interest only in the VIE.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 For the VIE types above, we do not consolidate the VIE because we
 do not have the ability to control the activities (such as the
 day-to-day healthcare operations of our borrowers or investees)
 that most significantly impact the VIE&amp;#x2019;s economic
 performance. As of March&amp;#xA0;31, 2015, we were not required to
 provide financial support through a liquidity arrangement or
 otherwise to our unconsolidated VIEs, including circumstances in
 which it could be exposed to further losses (e.g., cash short
 falls).&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 Typically, our loans are collateralized by assets of the borrower
 (some assets of which are on the premises of facilities owned by
 us) and further supported by limited guarantees made by certain
 principals of the borrower.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 See Note 3 for additional description of the nature, purpose and
 activities of our more significant VIEs and interests therein.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:SubsequentEventsTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_F96990C5-06D7-4CC5-A4A9-5A9070FB45C3_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;10. Subsequent Events&lt;/b&gt;&lt;/p&gt;
 &lt;!-- xbrl,body --&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 In April 2015, we executed an agreement with Adeptus Health that
 provides for the acquisition and development of general acute care
 hospitals and free standing emergency facilities with an aggregate
 commitment of $250 million. These facilities will be leased to
 Adeptus Health pursuant to the terms of the 2014 master lease
 agreement that has a 15-year initial term with three extension
 options of five years each that provides for annual rent increases
 based on changes in the consumer price index with a 2% minimum.&lt;/p&gt;


 &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
  <dei:EntityCentralIndexKey contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_6A94DFD6-FD91-454D-B669-5B289045196E_1_2">0001287865</dei:EntityCentralIndexKey>
  <us-gaap:CommonStockDividendsPerShareDeclared contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_35">0.22</us-gaap:CommonStockDividendsPerShareDeclared>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_63A6FD0F-8909-4141-AA48-7D2DF19C013C_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;b&gt;6. Stock Awards&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 We adopted the 2013 Equity Incentive Plan (the &amp;#x201C;Equity
 Incentive Plan&amp;#x201D;) during second quarter of 2013, which
 authorizes the issuance of common stock options, restricted stock,
 restricted stock units, deferred stock units, stock appreciation
 rights, performance units and awards of interests in our Operating
 Partnership. The Equity Incentive Plan is administered by the
 Compensation Committee of the Board of Directors. We have reserved
 7,643,651 shares of common stock for awards under the Equity
 Incentive Plan for which 5,417,878 shares remain available for
 future stock awards as of March&amp;#xA0;31, 2015. We awarded the
 following during the 2015 and 2014 first quarters:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; MARGIN-LEFT: 62px; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Time-based awards&lt;/i&gt;&amp;#x2014;We granted 217,177 and 338,484
 shares in 2015 and 2014, respectively, of time-based restricted
 stock to management, independent directors and certain employees.
 These awards vest quarterly based on service, over three years, in
 equal amounts.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; MARGIN-LEFT: 62px; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Performance-based awards&lt;/i&gt;&amp;#x2014;Our management team and
 certain employees were awarded 176,046 and 317,254 performance
 based awards in 2015 and 2014, respectively. These awards vest
 ratably over a three year period based on the achievement of
 certain total shareholder return measures, with a carry-back and
 carry-forward provision through December&amp;#xA0;31, 2018 (for the
 2014 awards) and December&amp;#xA0;31, 2017 (for the 2015 awards).
 Dividends on these awards are paid only upon achievement of the
 performance measures.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; MARGIN-LEFT: 62px; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Multi-year Performance-based awards&lt;/i&gt;&amp;#x2014;We awarded 505,050
 and 500,000 shares in 2015 and 2014, respectively, of multi-year
 performance-based awards to management. These shares are subject to
 three-year cumulative performance hurdles based on measures of
 total shareholder return. At the end of the three-year performance
 period, any earned shares will be subject to an additional two
 years of ratable time-based vesting on an annual basis. Dividends
 are paid on these shares only upon achievement of the performance
 measures.&lt;/p&gt;


 &lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_6DE672B9-25E9-4BA7-80B5-4A419980C1A2_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;b&gt;7. Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 We have various assets and liabilities that are considered
 financial instruments. We estimate that the carrying value of cash
 and cash equivalents, and accounts payable and accrued expenses
 approximate their fair values. Included in our accounts payable and
 accrued expenses are our interest rate swaps, which are recorded at
 fair value based on Level 2 observable market assumptions using
 standardized derivative pricing models. We estimate the fair value
 of our interest and rent receivables using Level 2 inputs such as
 discounting the estimated future cash flows using the current rates
 at which similar receivables would be made to others with similar
 credit ratings and for the same remaining maturities. The fair
 value of our mortgage loans and working capital loans are estimated
 by using Level 2 inputs such as discounting the estimated future
 cash flows using the current rates which similar loans would be
 made to borrowers with similar credit ratings and for the same
 remaining maturities. We determine the fair value of our senior
 unsecured notes (excluding our 2006 Senior Unsecured Notes) using
 Level 2 inputs such as quotes from securities dealers and market
 makers. We estimate the fair value of our 2006 Senior Unsecured
 Notes, revolving credit facilities, and term loans using Level 2
 inputs based on the present value of future payments, discounted at
 a rate which we consider appropriate for such debt.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 Fair value estimates are made at a specific point in time, are
 subjective in nature, and involve uncertainties and matters of
 significant judgment. Settlement of such fair value amounts may not
 be possible and may not be a prudent management decision. The
 following table summarizes fair value estimates for our financial
 instruments (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="56%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;March&amp;#xA0;31,&lt;br /&gt;
 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;br /&gt;
 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 54.75pt"&gt;
 &lt;b&gt;Asset (Liability)&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Book&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Fair&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Book&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Fair&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Interest and rent receivables&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;40,464&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;40,324&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;41,137&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;41,005&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Loans (1)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;837,098&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;867,523&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;773,311&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;803,824&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Debt, net&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,882,319&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,981,158&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,201,654&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,285,727&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(1)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Excludes loans related to Ernest
 since they are recorded at fair value and discussed below.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 18px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &lt;i&gt;Items Measured at Fair Value on a Recurring Basis&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 Our equity interest in Ernest and related loans, which were
 acquired in 2012, are being measured at fair value on a recurring
 basis as we elected to account for these investments using the fair
 value option method. We have elected to account for these
 investments at fair value due to the size of the investments and
 because we believe this method is more reflective of current
 values. We have not made a similar election for other equity
 interests or loans in or prior to 2015.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 At March&amp;#xA0;31, 2015, these amounts were as follows (in
 thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="63%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 37.55pt"&gt;
 &lt;b&gt;Asset Type&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Fair&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center"&gt;&lt;b&gt;Asset&amp;#xA0;Type&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;Classification&lt;/b&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Mortgage loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;100,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;100,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;Mortgage&amp;#xA0;loans&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Acquisition loan&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;102,450&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;102,450&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;Other&amp;#xA0;loans&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Equity investments&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,300&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3,300&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;Other&amp;#xA0;assets&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;205,750&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;205,750&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 Our mortgage loans with Ernest are recorded at fair value based on
 Level 3 inputs by discounting the estimated cash flows using the
 market rates which similar loans would be made to borrowers with
 similar credit ratings and the same remaining maturities. Our
 acquisition loans and equity investments in Ernest are recorded at
 fair value based on Level 3 inputs, by using a discounted cash flow
 model, which requires significant estimates of our investee such as
 projected revenue and expenses and appropriate consideration of the
 underlying risk profile of the forecast assumptions associated with
 the investee. We classify these loans and equity investments as
 Level 3, as we use certain unobservable inputs to the valuation
 methodology that are significant to the fair value measurement, and
 the valuation requires management judgment due to the absence of
 quoted market prices. For these cash flow models, our observable
 inputs include use of a capitalization rate, discount rate (which
 is based on a weighted-average cost of capital), and market
 interest rates, and our unobservable input includes an adjustment
 for a marketability discount (&amp;#x201C;DLOM&amp;#x201D;) on our equity
 investment of 40% at March&amp;#xA0;31, 2015.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 1px &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 12px; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 In regards to the underlying projection of revenues and expenses
 used in the discounted cash flow model, such projections are
 provided by Ernest. However, we will modify such projections
 (including underlying assumptions used) as needed based on our
 review and analysis of Ernest&amp;#x2019;s historical results, meetings
 with key members of management, and our understanding of trends and
 developments within the healthcare industry.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 In arriving at the DLOM, we started with a DLOM range based on the
 results of studies supporting valuation discounts for other
 transactions or structures without a public market. To select the
 appropriate DLOM within the range, we then considered many
 qualitative factors including the percent of control, the nature of
 the underlying investee&amp;#x2019;s business along with our rights as
 an investor pursuant to the operating agreement, the size of
 investment, expected holding period, number of shareholders, access
 to capital marketplace, etc. To illustrate the effect of movements
 in the DLOM, we performed a sensitivity analysis below by using
 basis point variations (dollars in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="69%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="27%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Basis Point&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Change in&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 1pt; FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; MARGIN-TOP: 0pt; WIDTH: 79.65pt"&gt;
 &lt;b&gt;Marketability Discount&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;
 &lt;b&gt;Estimated&amp;#xA0;Increase&amp;#xA0;(Decrease)&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;In Fair Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 +100 basis points&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(443&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 - 100 basis points&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;443&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 Because the fair value of Ernest investments noted above
 approximate their original cost, we did not recognize any
 unrealized gains/losses during the first quarter of 2015 or 2014.
 To date, we have not received any distribution payments from our
 equity investment in Ernest.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD_per_shares" decimals="0" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_32">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_A08DDEEC-A608-476C-91F9-A00E6B8F3EFA_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 4%; MARGIN-TOP: 18pt"&gt;
 &lt;i&gt;Recent Accounting Developments:&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 8%"&gt;
 &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 In May 2014, the Financial Accounting Standards Board
 (&amp;#x201C;FASB&amp;#x201D;) issued Accounting Standards Update
 (&amp;#x201C;ASU&amp;#x201D;) No.&amp;#xA0;2014-09, &amp;#x201C;Revenue from Contracts
 with Customers.&amp;#x201D; Under the new standard, revenue is
 recognized at the time a good or service is transferred to a
 customer for the amount of consideration received for that specific
 good or service.&amp;#xA0;Entities may use a full retrospective
 approach or report the cumulative effect as of the date of
 adoption.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 On April&amp;#xA0;1, 2015, the FASB proposed deferring the effective
 date by one year to December&amp;#xA0;15, 2017, for annual reporting
 periods beginning after that date. The FASB also proposed
 permitting early adoption of the standard, but not before the
 original effective date of December&amp;#xA0;15, 2016. We are currently
 evaluating the impact, if any, the adoption of this standard will
 have on our consolidated financial statements.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 18px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 8%"&gt;
 &lt;i&gt;Presentation of Debt Issuance Costs&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 In April 2015, the FASB issued ASU No.&amp;#xA0;2015-03,
 &amp;#x201C;Simplifying the Presentation of Debt Issuance Costs.&amp;#x201D;
 This standard amends existing guidance to require the presentation
 of debt issuance costs in the balance sheet as a deduction from the
 carrying amount of the related debt liability instead of a deferred
 charge. It is effective for annual reporting periods beginning
 after December&amp;#xA0;15, 2015, but early adoption is permitted.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt; TEXT-INDENT: 8%"&gt;
 &lt;i&gt;Amendments to the Consolidation Analysis&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 In February 2015, the FASB issued an ASU 2015-02 that modifies the
 evaluation of whether limited partnerships and similar legal
 entities are VIEs, eliminates the presumption that a general
 partner should consolidate a limited partnership and affects the
 consolidation analysis of reporting entities that are involved with
 VIEs, particularly those that have fee arrangements and related
 party relationships. The guidance is effective for fiscal years
 beginning after December 15, 2015, but early adoption is
 permitted.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:ScheduleOfDebtTableTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_CCCE7652-8B4C-4EF0-A0CF-EA699265C435_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 The following is a summary of debt, net of discounts (dollar
 amounts in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="56%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="2%"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&amp;#xA0;March&amp;#xA0;31,
 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&amp;#xA0;December&amp;#xA0;31,
 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Balance&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Interest&amp;#xA0;Rate&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Balance&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Interest&amp;#xA0;Rate&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Revolving credit facility&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;301,655&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Variable&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;593,490&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Variable&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2006 Senior Unsecured Notes&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;125,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;125,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2011 Senior Unsecured Notes&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;450,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.875%&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;450,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.875%&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2012 Senior Unsecured Notes:&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Principal amount&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;350,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.375%&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;350,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6.375%&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Unamortized premium&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,433&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,522&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;352,433&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;352,522&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1pt"&gt;
 &lt;td height="8"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="4"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="4"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="4"&gt;&lt;/td&gt;
 &lt;td height="8" colspan="4"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2013 Senior Unsecured Notes (A)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;214,620&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.750%&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;241,960&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.750%&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2014 Senior Unsecured Notes&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;300,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.500%&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;300,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5.500%&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Term loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;138,611&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;138,682&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,882,319&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,201,654&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(A)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;These notes are Euro-denominated and
 reflect the exchange rate at March&amp;#xA0;31, 2015 and
 December&amp;#xA0;31, 2014, respectively.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
  <dei:DocumentFiscalPeriodFocus contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_5971E97C-1419-4316-8F57-7E149560F042_1_4">Q1</dei:DocumentFiscalPeriodFocus>
  <us-gaap:ConsolidationVariableInterestEntityPolicy contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_3FDD9589-5534-4DE1-8952-5F35065AF472_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt; TEXT-INDENT: 4%"&gt;
 &lt;i&gt;Variable Interest Entities&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 At March&amp;#xA0;31, 2015, we had loans to and/or equity investments
 in certain variable interest entities (&amp;#x201C;VIEs&amp;#x201D;), which
 are also tenants of our facilities, including Ernest. We have
 determined that we are not the primary beneficiary of these VIEs.
 The carrying value and classification of the related assets and
 maximum exposure to loss as a result of our involvement with these
 VIEs are presented below at March&amp;#xA0;31, 2015 (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;&lt;!-- Begin Table Head --&gt;
 &lt;tr&gt;
 &lt;td width="51%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 33.6pt"&gt;
 &lt;b&gt;VIE Type&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Maximum&amp;#xA0;Loss&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;Exposure(1)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center"&gt;&lt;b&gt;Asset&amp;#xA0;Type&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;Classification&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 Amount(2)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Head --&gt;&lt;!-- Begin Table Body --&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Loans, net&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;264,397&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;
 Mortgage&amp;#xA0;and&amp;#xA0;other&amp;#xA0;loans&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;
 &amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;212,196&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Equity investments&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;59,228&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;Other&amp;#xA0;assets&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,324&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Body --&gt;&lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(1)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Our maximum loss exposure related to
 loans with VIEs represents our current aggregate gross carrying
 value of the loan plus accrued interest and any other related
 assets (such as rents receivable), less any liabilities. Our
 maximum loss exposure related to our equity investment in VIEs
 represents the current carrying values of such investment plus any
 other related assets (such as rent receivables) less any
 liabilities.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(2)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Carrying amount reflects the net book
 value of our loan or equity interest only in the VIE.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 For the VIE types above, we do not consolidate the VIE because we
 do not have the ability to control the activities (such as the
 day-to-day healthcare operations of our borrowers or investees)
 that most significantly impact the VIE&amp;#x2019;s economic
 performance. As of March&amp;#xA0;31, 2015, we were not required to
 provide financial support through a liquidity arrangement or
 otherwise to our unconsolidated VIEs, including circumstances in
 which it could be exposed to further losses (e.g., cash short
 falls).&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 Typically, our loans are collateralized by assets of the borrower
 (some assets of which are on the premises of facilities owned by
 us) and further supported by limited guarantees made by certain
 principals of the borrower.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 See Note 3 for additional description of the nature, purpose and
 activities of our more significant VIEs and interests therein.&lt;/p&gt;
 &lt;/div&gt;</us-gaap:ConsolidationVariableInterestEntityPolicy>
  <us-gaap:FairValueByBalanceSheetGroupingTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_A879D106-E7E8-4490-8B93-B3542E242A30_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"&gt;
 The following table summarizes fair value estimates for our
 financial instruments (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="92%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="56%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="6%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="3%"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;March&amp;#xA0;31,&lt;br /&gt;
 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="6" align="center"&gt;&lt;b&gt;December&amp;#xA0;31,&lt;br /&gt;
 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="FONT-SIZE: 8pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 54.75pt"&gt;
 &lt;b&gt;Asset (Liability)&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Book&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Fair&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Book&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Fair&lt;br /&gt;
 Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Interest and rent receivables&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;40,464&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;40,324&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;41,137&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;41,005&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Loans (1)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;837,098&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;867,523&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;773,311&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;803,824&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Debt, net&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,882,319&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,981,158&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,201,654&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(2,285,727&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(1)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Excludes loans related to Ernest
 since they are recorded at fair value and discussed below.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;


 &lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
  <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_753553AF-5824-45D7-ACB6-2E67D414C343_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"&gt;
 As part of these acquisitions, we acquired the following
 assets:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;&lt;!-- Begin Table Head --&gt;
 &lt;tr&gt;
 &lt;td width="78%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Head --&gt;&lt;!-- Begin Table Body --&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Assets Acquired&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Land&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;21,591&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;8,515&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Building&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;88,409&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;99,602&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Intangible lease assets &amp;#x2014; subject to amortization (weighted
 average useful life 15&amp;#xA0;years)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6,883&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Mortgage loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;40,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Net investments in direct financing leases&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;10,700&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Other loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Total assets acquired&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;165,700&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;115,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
  <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_153636B9-52A8-4487-938B-F885BAFC5ACD_1_0">&lt;div&gt;
 The carrying value and classification of the related assets and
 maximum exposure to loss as a result of our involvement with these
 VIEs are presented below at March&amp;#xA0;31, 2015 (in thousands):
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="84%" align="center" border="0"&gt;&lt;!-- Begin Table Head --&gt;
 &lt;tr&gt;
 &lt;td width="51%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 33.6pt"&gt;
 &lt;b&gt;VIE Type&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Maximum&amp;#xA0;Loss&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;Exposure(1)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center"&gt;&lt;b&gt;Asset&amp;#xA0;Type&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;Classification&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Carrying&lt;br /&gt;
 Amount(2)&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Head --&gt;&lt;!-- Begin Table Body --&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Loans, net&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;264,397&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;
 Mortgage&amp;#xA0;and&amp;#xA0;other&amp;#xA0;loans&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;
 &amp;#xA0;&amp;#xA0;&amp;#xA0;&amp;#xA0;212,196&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Equity investments&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;59,228&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="center"&gt;Other&amp;#xA0;assets&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,324&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Body --&gt;&lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(1)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Our maximum loss exposure related to
 loans with VIEs represents our current aggregate gross carrying
 value of the loan plus accrued interest and any other related
 assets (such as rents receivable), less any liabilities. Our
 maximum loss exposure related to our equity investment in VIEs
 represents the current carrying values of such investment plus any
 other related assets (such as rent receivables) less any
 liabilities.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"&gt;
 &lt;tr&gt;
 &lt;td valign="top" width="4%" align="left"&gt;(2)&lt;/td&gt;
 &lt;td valign="top" align="left"&gt;Carrying amount reflects the net book
 value of our loan or equity interest only in the VIE.&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;


 &lt;/div&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="shares" decimals="-3" id="id_6193307_8FF78180-9D59-46F0-9398-291DBB99DDC4_1_6">202958000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:PaymentsOfOrdinaryDividends contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_24">38461000</us-gaap:PaymentsOfOrdinaryDividends>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_23">71000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:PaymentsToAcquireLoansReceivable contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_18">80301000</us-gaap:PaymentsToAcquireLoansReceivable>
  <us-gaap:ProfitLoss contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_22">35976000</us-gaap:ProfitLoss>
  <us-gaap:StraightLineRent contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_2">4728000</us-gaap:StraightLineRent>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_13">63710000</us-gaap:OperatingIncomeLoss>
  <us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_4">25578000</us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EB48F6C1-A97A-4316-B60F-4F3FDD06C0CC_1_6">-23111000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_19">-27734000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:PaymentsToAcquireRealEstate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_16">165700000</us-gaap:PaymentsToAcquireRealEstate>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_15">-796000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EB48F6C1-A97A-4316-B60F-4F3FDD06C0CC_1_2">585000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EB48F6C1-A97A-4316-B60F-4F3FDD06C0CC_1_3">-59593000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_3">12555000</us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue>
  <us-gaap:Revenues contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_5">95961000</us-gaap:Revenues>
  <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_10">1290000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:NetIncomeLoss contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_24">35897000</us-gaap:NetIncomeLoss>
  <us-gaap:InterestPaid contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_33">22832000</us-gaap:InterestPaid>
  <us-gaap:OtherNonoperatingIncome contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_16">103000</us-gaap:OtherNonoperatingIncome>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8FF78180-9D59-46F0-9398-291DBB99DDC4_1_0">35976000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EB48F6C1-A97A-4316-B60F-4F3FDD06C0CC_1_4">-23032000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_3">15074000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:InterestExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_17">26666000</us-gaap:InterestExpense>
  <us-gaap:ProceedsFromCollectionOfLoansReceivable contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_17">1466000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_9">1377000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:EffectOfExchangeRateOnCash contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_30">-2962000</us-gaap:EffectOfExchangeRateOnCash>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_29">-108031000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_18">375000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_20">-291046000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_7">14756000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_9">351000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_25">479966000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_27">-126000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_14_2">49266000</us-gaap:ContractRevenueCost>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_28">140989000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_11">6239000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:CostsAndExpenses contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_12">32251000</us-gaap:CostsAndExpenses>
  <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8FF78180-9D59-46F0-9398-291DBB99DDC4_1_1">79000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_10">10905000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_13">-6271000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_23">79000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_8">2825000</us-gaap:ShareBasedCompensation>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_EB48F6C1-A97A-4316-B60F-4F3FDD06C0CC_1_5">79000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <mpw:ProceedsFromLeaseDepositsAndOtherObligationsToTenants contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_26">-15319000</mpw:ProceedsFromLeaseDepositsAndOtherObligationsToTenants>
  <mpw:RevolvingCreditFacilitiesNet contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_22">285000000</mpw:RevolvingCreditFacilitiesNet>
  <mpw:RealEstateAndLoansReceivablesTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_D87B4D65-C839-4917-BD44-E6C00BDA381B_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;b&gt;3. Real Estate and Lending Activities&lt;/b&gt;&lt;/p&gt;
 &lt;!-- xbrl,body --&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;i&gt;Acquisitions&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"&gt;
 &lt;u&gt;2015 Activity&lt;/u&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 On February&amp;#xA0;13, 2015, we acquired two general acute care
 hospitals in the Kansas City area for $110 million. Affiliates of
 Prime Healthcare Services, Inc. (&amp;#x201C;Prime&amp;#x201D;) is the tenant
 and operator pursuant to a new master lease that has similar terms
 and security enhancements as the other master lease agreements
 entered into in 2013. This master lease has a 10 year initial fixed
 term with two extension options of five years each. The lease
 provides for consumer-price-indexed annual rent increases, subject
 to a specified floor. In addition, we agreed to fund a mortgage
 loan in the amount of $40 million, which has a 10-year term.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 On February&amp;#xA0;27, 2015, we acquired an inpatient rehabilitation
 hospital in Weslaco, Texas for $10.7 million leased to Ernest
 Health Inc. (&amp;#x201C;Ernest&amp;#x201D;) pursuant to the 2012 master
 lease which has a remaining 17-year fixed term and three five year
 extension options. This lease provides for consumer-priced-indexed
 annual rent increases, subject to a floor and a cap. In addition we
 agreed to fund an acquisition loan in the amount of $5 million.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; PAGE-BREAK-BEFORE: always; MARGIN-TOP: 0pt"&gt;
 &lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 In January 2015, we advanced the remaining &amp;#x20AC;63.1&amp;#xA0;million
 of the &amp;#x20AC;425&amp;#xA0;million interim acquisition loans to MEDIAN.
 In April 2015, we executed definitive agreements with MEDIAN to
 purchase and lease back 31 hospitals and expect these properties to
 close during the next 30 to 60 days, subject to expiration or
 waiver of local government preemptive rights. As these 31 hospitals
 (and others) close, the related purchase prices will be offset, pro
 rata, against any debt that we assume on these properties or
 against the interim acquisition loans that have been made.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;u&gt;2014 Activity&lt;/u&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 On March&amp;#xA0;31, 2014, we acquired a general acute care hospital
 and an adjacent parcel for an aggregate purchase price of $115
 million from a joint venture of LHP Hospital Group, Inc. and
 Hackensack University Medical Center Mountainside. The facility was
 simultaneously leased back to the seller under a lease with a
 15-year initial term with a 3-year extension option, followed by a
 further 12-year extension option at fair market value. The lease
 provides for consumer-price-indexed annual rent increases, subject
 to a specified floor and ceiling. The lease includes a customary
 right of first refusal with respect to a subsequent proposed sale
 of the facility.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"&gt;
 As part of these acquisitions, we acquired the following
 assets:&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;&lt;!-- Begin Table Head --&gt;
 &lt;tr&gt;
 &lt;td width="78%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="4%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Head --&gt;&lt;!-- Begin Table Body --&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;b&gt;Assets Acquired&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Land&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;21,591&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;8,515&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Building&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;88,409&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;99,602&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Intangible lease assets &amp;#x2014; subject to amortization (weighted
 average useful life 15&amp;#xA0;years)&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6,883&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Mortgage loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;40,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Net investments in direct financing leases&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;10,700&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Other loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap" align="right"&gt;
 &amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Total assets acquired&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;165,700&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;115,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Body --&gt;&lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"&gt;
 The purchase price allocations attributable to the 2015
 acquisitions are preliminary. When all relevant information is
 obtained, resulting changes, if any, to our provisional purchase
 price allocation will be retrospectively adjusted to reflect new
 information obtained about the facts and circumstances that existed
 as of the respective acquisition dates that, if known, would have
 affected the measurement of the amounts recognized as of those
 dates.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;i&gt;Development Activities&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 During the 2015 first quarter, we completed construction and began
 recording rental income on two acute care facilities for First
 Choice ER (a subsidiary of Adeptus Health). These facilities are
 leased pursuant to the master lease entered into in 2014 and are
 cross-defaulted with the original master lease executed with First
 Choice ER in 2013.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 In the first quarter of 2015, we began construction on six
 additional facilities pursuant to the master funding and
 development agreement with First Choice ER executed in 2014.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 See table below for a status update on our current development
 projects (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;&lt;!-- Begin Table Head --&gt;
 &lt;tr&gt;
 &lt;td width="19%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td width="18%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td width="19%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 30.65pt"&gt;
 &lt;b&gt;Property&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center"&gt;
 &lt;p style="MARGIN-BOTTOM: 1pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;Location&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center"&gt;&lt;b&gt;Property Type&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center"&gt;
 &lt;p style="MARGIN-BOTTOM: 1pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;Operator&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Commitment&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Costs&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;Incurred&lt;br /&gt;
 as of&lt;br /&gt;
 03/31/15&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 Completion&lt;br /&gt;
 Date&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Head --&gt;&lt;!-- Begin Table Body --&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 UAB&amp;#xA0;Medical&amp;#xA0;West&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Hoover, AL&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 Acute&amp;#xA0;Care&amp;#xA0;Hospital&amp;#xA0;&amp;amp;&amp;#xA0;MOB&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Medical&amp;#xA0;West,&amp;#xA0;an
 affiliate&amp;#xA0;of&amp;#xA0;UAB&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;8,653&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,853&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2Q&amp;#xA0;2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Chandler&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Chandler,&amp;#xA0;AZ&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,049&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,502&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Converse&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Converse,&amp;#xA0;TX&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,754&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4,311&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Denver&amp;#xA0;48&lt;/font&gt;&lt;sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top"&gt;th&lt;/sup&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Denver, CO&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,123&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,174&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Aurora&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Aurora, CO&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,273&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;21&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Conroe&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Houston,&amp;#xA0;TX&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute&amp;#xA0;Care&amp;#xA0;Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6,110&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,668&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q&amp;#xA0;2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Carrollton&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Carrollton,&amp;#xA0;TX&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;35,820&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;23,458&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Gilbert&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Gilbert, AZ&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6,500&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,481&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Glendale&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Glendale,&amp;#xA0;AZ&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4,824&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;564&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;McKinney&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;McKinney,&amp;#xA0;TX&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4,750&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,002&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Victory&amp;#xA0;Lakes&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Houston,&amp;#xA0;TX&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4,939&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;554&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Vintage&amp;#xA0;Preserve&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Houston,&amp;#xA0;TX&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;45,961&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,678&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q 2016&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 First&amp;#xA0;Choice&amp;#xA0;Emergency&amp;#xA0;Rooms&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;13,448&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;b&gt;152,204&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;b&gt;&amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;b&gt;49,266&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;b&gt;&amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Body --&gt;&lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 18px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;i&gt;Leasing Operations&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 All of our leases are accounted for as operating leases except for
 the master lease of 15 Ernest facilities and five Prime facilities
 which are accounted for as direct financing leases
 (&amp;#x201C;DFLs&amp;#x201D;). The components of our net investment in DFLs
 consisted of the following (dollars in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;&lt;!-- Begin Table Head --&gt;
 &lt;tr&gt;
 &lt;td width="66%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="8%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="8%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&amp;#xA0;March&amp;#xA0;31,&lt;br /&gt;
 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;
 &lt;b&gt;As&amp;#xA0;of&amp;#xA0;December&amp;#xA0;31,&lt;br /&gt;
 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Head --&gt;&lt;!-- Begin Table Body --&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Minimum lease payments receivable&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,639,128&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,607,024&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Estimated residual values&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;225,871&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;211,888&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Less: Unearned income&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,411,576&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,379,396&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Net investment in direct financing leases&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;453,423&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;439,516&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Body --&gt;&lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;u&gt;Florence facility&lt;/u&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 On March&amp;#xA0;6, 2013, the tenant of our $27.2 million facility in
 Phoenix, Arizona filed for Chapter 11 bankruptcy. At March&amp;#xA0;31,
 2015, we have approximately $1.1 million of receivables outstanding
 but the tenant continues to pay us in accordance with bankruptcy
 orders. In addition, we have a letter of credit for approximately
 $1.2 million to cover any rent and other monetary payments not
 paid. We have entered into a non-binding letter of intent with the
 stalking horse bidder for the assumption of the existing lease,
 with certain non-monetary amendments. Although no assurances can be
 made that we will not have any impairment charges in the future, we
 believe our investment in Florence at March&amp;#xA0;31, 2015 is fully
 recoverable.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;u&gt;Gilbert facility&lt;/u&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 In the first quarter of 2014, the tenant of our facility in
 Gilbert, Arizona filed for Chapter 11 bankruptcy; however, we sent
 notice of termination of the lease prior to the bankruptcy filing.
 As a result of the lease terminating, we recorded a charge of
 approximately $1 million to reserve against the straight-line rent
 receivables. In addition, we accelerated the amortization of the
 related lease intangible asset resulting in $1.1 million of
 additional expense in the 2014 first quarter. The tenant has
 continued to perform its monetary obligations, and we have agreed
 to the terms of an amended lease upon the tenant&amp;#x2019;s bankruptcy
 exit. Although no assurances can be made that we will not have any
 impairment charges or write-offs of receivables in the future, we
 believe our real estate investment in Gilbert of $14.1 million at
 March&amp;#xA0;31, 2015 is fully recoverable.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;i&gt;Loans&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The following is a summary of our loans (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;&lt;!-- Begin Table Head --&gt;
 &lt;tr&gt;
 &lt;td width="74%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&lt;br /&gt;
 March&amp;#xA0;31,&lt;br /&gt;
 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&lt;br /&gt;
 December&amp;#xA0;31,&lt;br /&gt;
 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Head --&gt;&lt;!-- Begin Table Body --&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Mortgage loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;437,591&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;397,594&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Acquisition loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;555,391&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;525,136&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Working capital and other loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;46,566&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;48,031&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,039,548&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;970,761&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Body --&gt;&lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 Our non-mortgage loans typically consist of loans to our tenants
 for acquisitions and working capital purposes. At March&amp;#xA0;31,
 2015, acquisition loans includes our $102.5 million loans to Ernest
 plus $442.4 million related to the MEDIAN Kliniken S.&amp;#xE0; r.l.
 (&amp;#x201C;MEDIAN&amp;#x201D;), transaction in 2014.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 On March&amp;#xA0;1, 2012, pursuant to our convertible note agreement,
 we converted $1.7&amp;#xA0;million of our $5.0&amp;#xA0;million convertible
 note into a 9.9% equity interest in the operator of our Hoboken
 University Medical Center facility. At March&amp;#xA0;31, 2015,
 $3.3&amp;#xA0;million remains outstanding on the convertible note, and
 we retain the option, subject to regulatory approvals, to convert
 this remainder into 15.1% of equity interest in the operator.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"&gt;
 &lt;i&gt;Concentrations of Credit Risk&lt;/i&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 For the three months ended March&amp;#xA0;31, 2015 and 2014, revenue
 from affiliates of Prime (including rent and interest from mortgage
 loans) accounted for 25.0% and 29.1%, respectively, of total
 revenue. From an investment concentration perspective, assets
 leased and loaned to Prime represented 15.2% and 8.3%, respectively
 of our total assets, at March&amp;#xA0;31, 2015. Assets leased and
 loaned to Prime represented 12.6% and 7.4%, respectively, of our
 total assets at December&amp;#xA0;31, 2014.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"&gt;
 For the three months ended March&amp;#xA0;31, 2015, revenue from
 affiliates of MEDIAN accounted for 9.5% of total revenue. From an
 investment concentration perspective, MEDIAN represented 11.6% and
 11.3% of our total assets at March&amp;#xA0;31, 2015 and
 December&amp;#xA0;31, 2014, respectively.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 For the three months ended March&amp;#xA0;31, 2015 and 2014, revenue
 from affiliates of Ernest (including rent and interest from
 mortgage and acquisition loans) accounted for 15.3% and 19.6% of
 total revenue, respectively. From an investment concentration
 perspective, assets leased and loaned to Ernest represented 7.9%
 and 5.3%, respectively, of our total assets at March 31, 2015.
 Assets leased and loaned to Ernest represented 7.7% and 5.3%,
 respectively, of our total assets at December 31, 2014.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 On an individual property basis, we had no investment of any single
 property greater than 4% of our total assets as of March&amp;#xA0;31,
 2015.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 From a global geographic perspective, approximately 80% of our
 total assets are in the United States while 20% reside in Europe as
 of March&amp;#xA0;31, 2015 and December&amp;#xA0;31, 2014. Revenue from our
 European investments was $16.3 million and $5.5 million in the
 first quarter of 2015 and 2014, respectively.&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 From a United States geographic perspective, investments located in
 California represented 14.3% of our total assets at March&amp;#xA0;31,
 2015, compared to 14.6% at December&amp;#xA0;31, 2014. Investments
 located in Texas represented 20.5% of our total assets at
 March&amp;#xA0;31, 2015, compared to 20.2% at December&amp;#xA0;31,
 2014.&lt;/p&gt;
 &lt;/div&gt;</mpw:RealEstateAndLoansReceivablesTextBlock>
  <mpw:PercentageOfDividendsPayableOnSeniorUnsecuredNotes contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="pure" decimals="INF" id="id_6193307_4B775DF3-E0A1-4926-B15E-DDBFB2DF9430_1_1">0.95</mpw:PercentageOfDividendsPayableOnSeniorUnsecuredNotes>
  <mpw:ConstructionInProgressEquipmentAndOther contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_19">46511000</mpw:ConstructionInProgressEquipmentAndOther>
  <mpw:FairValueAssumptionsAndMethodologyForAssetsAndLiabilitiesTableTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_1CC63676-6A5E-4911-83B4-2BBC3FB20247_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 To illustrate the effect of movements in the DLOM, we performed a
 sensitivity analysis below by using basis point variations (dollars
 in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="69%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="27%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Basis Point&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"&gt;
 &lt;b&gt;Change in&lt;/b&gt;&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 1pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-BOTTOM: #000000 1pt solid; MARGIN-TOP: 0pt; WIDTH: 79.65pt"&gt;
 &lt;b&gt;Marketability Discount&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center"&gt;
 &lt;b&gt;Estimated&amp;#xA0;Increase&amp;#xA0;(Decrease)&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;In Fair Value&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 +100 basis points&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(443&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 - 100 basis points&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;443&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</mpw:FairValueAssumptionsAndMethodologyForAssetsAndLiabilitiesTableTextBlock>
  <mpw:FuturePrincipalPaymentsTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_902D3BB2-C95B-4715-ADAC-DB6BEB6544C9_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 As of March&amp;#xA0;31, 2015, principal payments due on our debt
 (which exclude the effects of any discounts or premiums recorded)
 are as follows (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 12pt &apos;Times New Roman&apos;; WIDOWS: 1; MARGIN-TOP: 0pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="68%" align="center" border="0"&gt;
 &lt;tr&gt;
 &lt;td width="85%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2015&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;211&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2016&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;125,299&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2017&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;320&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2018&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;314,436&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 2019&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;125,000&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Thereafter&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,314,620&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: &apos;Times New Roman&apos;; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Total&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,879,886&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;br class="Apple-interchange-newline" /&gt;&lt;/div&gt;</mpw:FuturePrincipalPaymentsTextBlock>
  <mpw:StraightLineRentRevenue contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_5">4728000</mpw:StraightLineRentRevenue>
  <mpw:ScheduleOfDevelopmentProjectsTableTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_796918DE-C1F0-4B77-B876-29ED13B18052_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt; TEXT-INDENT: 4%"&gt;
 See table below for a status update on our current development
 projects (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt;&lt;!-- Begin Table Head --&gt;
 &lt;tr&gt;
 &lt;td width="19%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td width="18%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td width="19%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="1%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;
 &lt;p style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; BORDER-BOTTOM: rgb(0,0,0) 1pt solid; WIDTH: 30.65pt"&gt;
 &lt;b&gt;Property&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center"&gt;
 &lt;p style="MARGIN-BOTTOM: 1pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;Location&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center"&gt;&lt;b&gt;Property Type&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" align="center"&gt;
 &lt;p style="MARGIN-BOTTOM: 1pt; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt" align="center"&gt;&lt;b&gt;Operator&lt;/b&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Commitment&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Costs&lt;/b&gt;&lt;br /&gt;
 &lt;b&gt;Incurred&lt;br /&gt;
 as of&lt;br /&gt;
 03/31/15&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;Estimated&lt;br /&gt;
 Completion&lt;br /&gt;
 Date&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Head --&gt;&lt;!-- Begin Table Body --&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 UAB&amp;#xA0;Medical&amp;#xA0;West&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Hoover, AL&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 Acute&amp;#xA0;Care&amp;#xA0;Hospital&amp;#xA0;&amp;amp;&amp;#xA0;MOB&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Medical&amp;#xA0;West,&amp;#xA0;an
 affiliate&amp;#xA0;of&amp;#xA0;UAB&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;8,653&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,853&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2Q&amp;#xA0;2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Chandler&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Chandler,&amp;#xA0;AZ&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,049&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,502&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Converse&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Converse,&amp;#xA0;TX&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,754&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4,311&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Denver&amp;#xA0;48&lt;/font&gt;&lt;sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: top"&gt;th&lt;/sup&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Denver, CO&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,123&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,174&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Aurora&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Aurora, CO&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,273&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;21&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Conroe&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Houston,&amp;#xA0;TX&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute&amp;#xA0;Care&amp;#xA0;Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6,110&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,668&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q&amp;#xA0;2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Carrollton&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Carrollton,&amp;#xA0;TX&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;35,820&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;23,458&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Gilbert&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Gilbert, AZ&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;6,500&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;2,481&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Glendale&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Glendale,&amp;#xA0;AZ&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4,824&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;564&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;McKinney&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;McKinney,&amp;#xA0;TX&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4,750&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,002&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Victory&amp;#xA0;Lakes&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Houston,&amp;#xA0;TX&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;4,939&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;554&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q 2015&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 &lt;font style="WHITE-SPACE: nowrap"&gt;First&amp;#xA0;Choice&amp;#xA0;ER-&amp;#xA0;Vintage&amp;#xA0;Preserve&lt;/font&gt;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Houston,&amp;#xA0;TX&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;45,961&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;5,678&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;3Q 2016&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 First&amp;#xA0;Choice&amp;#xA0;Emergency&amp;#xA0;Rooms&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Acute Care Hospital&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;Adeptus Health&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;13,448&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&amp;#x2014;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;Various&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;b&gt;152,204&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;b&gt;&amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;&lt;b&gt;49,266&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&lt;b&gt;&amp;#xA0;&amp;#xA0;&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Body --&gt;&lt;/table&gt;
 &lt;p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 18px"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;/div&gt;</mpw:ScheduleOfDevelopmentProjectsTableTextBlock>
  <mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8FF78180-9D59-46F0-9398-291DBB99DDC4_1_3">35631000</mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings>
  <mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8FF78180-9D59-46F0-9398-291DBB99DDC4_1_5">35631000</mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings>
  <mpw:RentBilled contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_2010DED3-98D1-4C12-9CAC-F5E55B764DEE_1_1">53100000</mpw:RentBilled>
  <mpw:PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="pure" decimals="INF" id="id_6193307_4B775DF3-E0A1-4926-B15E-DDBFB2DF9430_1_0">0.95</mpw:PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds>
  <mpw:PercentageOfEquitySharesFromConvertibleDebt contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="pure" decimals="INF" id="id_6193307_CC171053-2138-4DEA-8B37-91AF27184B83_2_2">0.151</mpw:PercentageOfEquitySharesFromConvertibleDebt>
  <mpw:ComponentsOfInvestmentInLeasesOfEquipmentTableTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_C6844ED5-FE01-4D05-96FF-AA5D9F4E8838_1_0">&lt;div&gt;The components of our net investment in DFLs consisted of the
 following (dollars in thousands):
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;&lt;!-- Begin Table Head --&gt;
 &lt;tr&gt;
 &lt;td width="66%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="8%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="8%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&amp;#xA0;March&amp;#xA0;31,&lt;br /&gt;
 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;
 &lt;b&gt;As&amp;#xA0;of&amp;#xA0;December&amp;#xA0;31,&lt;br /&gt;
 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Head --&gt;&lt;!-- Begin Table Body --&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Minimum lease payments receivable&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,639,128&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,607,024&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Estimated residual values&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;225,871&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;211,888&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Less: Unearned income&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,411,576&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;(1,379,396&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;)&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 3em; TEXT-INDENT: -1em"&gt;
 Net investment in direct financing leases&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;453,423&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;439,516&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</mpw:ComponentsOfInvestmentInLeasesOfEquipmentTableTextBlock>
  <mpw:ScheduleOfLoansReceivableTableTextBlock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" id="id_6193307_F124EFEE-989A-48BB-BA60-0A57BE3E4B2B_1_0">&lt;div&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"&gt;
 The following is a summary of our loans (in thousands):&lt;/p&gt;
 &lt;p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 12pt; MARGIN-TOP: 0pt"&gt;
 &amp;#xA0;&lt;/p&gt;
 &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="76%" align="center" border="0"&gt;&lt;!-- Begin Table Head --&gt;
 &lt;tr&gt;
 &lt;td width="74%"&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td valign="bottom" width="5%"&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;td&gt;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&lt;br /&gt;
 March&amp;#xA0;31,&lt;br /&gt;
 2015&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td style="BORDER-BOTTOM: rgb(0,0,0) 1pt solid" valign="bottom" colspan="2" align="center"&gt;&lt;b&gt;As&amp;#xA0;of&lt;br /&gt;
 December&amp;#xA0;31,&lt;br /&gt;
 2014&lt;/b&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;!-- End Table Head --&gt;&lt;!-- Begin Table Body --&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Mortgage loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;437,591&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;397,594&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Acquisition loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;555,391&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;525,136&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" bgcolor="#CCEEFF"&gt;
 &lt;td valign="top"&gt;
 &lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 1em; TEXT-INDENT: -1em"&gt;
 Working capital and other loans&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;46,566&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;48,031&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 1px solid"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
 &lt;td valign="top"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;1,039,548&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;$&lt;/td&gt;
 &lt;td valign="bottom" align="right"&gt;970,761&lt;/td&gt;
 &lt;td valign="bottom" nowrap="nowrap"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr style="FONT-SIZE: 1px"&gt;
 &lt;td valign="bottom"&gt;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td&gt;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;&amp;#xA0;&amp;#xA0;&lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;td valign="bottom"&gt;
 &lt;p style="BORDER-TOP: rgb(0,0,0) 3px double"&gt;&amp;#xA0;&lt;/p&gt;
 &lt;/td&gt;
 &lt;/tr&gt;
 &lt;/table&gt;
 &lt;/div&gt;</mpw:ScheduleOfLoansReceivableTableTextBlock>
  <mpw:IncreaseDecreaseInInterestAndRentReceivable contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_12">-667000</mpw:IncreaseDecreaseInInterestAndRentReceivable>
  <mpw:MaximumPercentageOfUnencumberedAssets contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="pure" decimals="INF" id="id_6193307_4B775DF3-E0A1-4926-B15E-DDBFB2DF9430_1_2">1.50</mpw:MaximumPercentageOfUnencumberedAssets>
  <mpw:RecognitionOfUnearnedIncomeOnDirectFinancingAndSalesTypeLeases contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_DBA7D4CD-968E-43A9-9B6D-85C9FED3AE1E_1_4">1604000</mpw:RecognitionOfUnearnedIncomeOnDirectFinancingAndSalesTypeLeases>
  <mpw:UndistributedEarningAllocatedToParticipatingSecurities contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8FF78180-9D59-46F0-9398-291DBB99DDC4_1_2">266000</mpw:UndistributedEarningAllocatedToParticipatingSecurities>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_901822x1064668" unitRef="shares" decimals="INF" id="id_6193307_BE583270-B49A-4FDE-98C3-63FB27A943CC_1001_0">505050</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_901822x1064668" id="id_6193307_BE583270-B49A-4FDE-98C3-63FB27A943CC_1001_1">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_901822x905956" unitRef="shares" decimals="INF" id="id_6193307_76B51B2D-B01A-4E77-B90B-A4F5337F8D02_1001_0">176046</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_901822x905956" id="id_6193307_76B51B2D-B01A-4E77-B90B-A4F5337F8D02_1001_1">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_901822x992702" unitRef="shares" decimals="INF" id="id_6193307_7DF499F2-12C8-46BD-9DB8-499AB3145CAA_1001_0">217177</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_901822x992702" id="id_6193307_7DF499F2-12C8-46BD-9DB8-499AB3145CAA_1001_1">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x906990_907439x925328_908551x904419" unitRef="pure" decimals="3" id="id_6193307_095224FA-BB23-4CCC-8BFF-BEB1E7432E80_1001_0">0.095</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x906990_907439x925328_908551x905169" unitRef="pure" decimals="3" id="id_6193307_095224FA-BB23-4CCC-8BFF-BEB1E7432E80_2001_1">0.116</us-gaap:ConcentrationRiskPercentage1>
  <mpw:PercentageOfAssetsLeased contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x906990_907439x937635" unitRef="pure" decimals="3" id="id_6193307_6042362D-31E0-43FC-B5E1-13FEDDAE3BA4_1001_1">0.152</mpw:PercentageOfAssetsLeased>
  <mpw:PercentageOfAssetsLoaned contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x906990_907439x937635" unitRef="pure" decimals="3" id="id_6193307_6042362D-31E0-43FC-B5E1-13FEDDAE3BA4_1001_2">0.083</mpw:PercentageOfAssetsLoaned>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x906990_907439x937635_908551x904419" unitRef="pure" decimals="3" id="id_6193307_6042362D-31E0-43FC-B5E1-13FEDDAE3BA4_2001_0">0.250</us-gaap:ConcentrationRiskPercentage1>
  <mpw:PercentageOfAssetsLeased contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x906990_907439x948370" unitRef="pure" decimals="3" id="id_6193307_A94D596E-F2FB-4ABB-8EAB-DAD8D0119ADE_1001_2">0.079</mpw:PercentageOfAssetsLeased>
  <mpw:PercentageOfAssetsLoaned contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x906990_907439x948370" unitRef="pure" decimals="3" id="id_6193307_A94D596E-F2FB-4ABB-8EAB-DAD8D0119ADE_1001_3">0.053</mpw:PercentageOfAssetsLoaned>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x906990_907439x948370_908551x904419" unitRef="pure" decimals="3" id="id_6193307_A94D596E-F2FB-4ABB-8EAB-DAD8D0119ADE_2001_0">0.153</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x907273_904842x902145_908551x905169" unitRef="pure" decimals="2" id="id_6193307_16DECFE3-A282-4067-9BBE-72D33EF424B9_1001_2">0.80</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x907273_904842x903009_908551x905169" unitRef="pure" decimals="2" id="id_6193307_16DECFE3-A282-4067-9BBE-72D33EF424B9_2001_0">0.80</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x907273_904842x906342_908551x905169" unitRef="pure" decimals="3" id="id_6193307_98D65352-28ED-40EA-9D81-CA81E8528885_1001_0">0.143</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ConcentrationRiskPercentage1 contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x907273_904842x906348_908551x905169" unitRef="pure" decimals="3" id="id_6193307_98D65352-28ED-40EA-9D81-CA81E8528885_2001_1">0.205</us-gaap:ConcentrationRiskPercentage1>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1085855_907440x1085859_908021x1085858_908505x1087026" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_1_2">5853000</us-gaap:ContractRevenueCost>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1085855_907440x1085859_908021x1085858_908505x1087026" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_1_3">2Q 2015</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1092391_907440x1082744_908021x991433_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_13_2">0</us-gaap:ContractRevenueCost>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1092391_907440x1082744_908021x991433_908505x1082625" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_13_3">Various</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1093693_907440x1082744_908021x1093700_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_7_2">23458000</us-gaap:ContractRevenueCost>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1093693_907440x1082744_908021x1093700_908505x1082625" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_7_3">3Q 2015</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1093695_907440x1082744_908021x1093701_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_2_2">2502000</us-gaap:ContractRevenueCost>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1093695_907440x1082744_908021x1093701_908505x1082625" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_2_3">2Q 2015</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1093696_907440x1082744_908021x1093702_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_3_2">4311000</us-gaap:ContractRevenueCost>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1093696_907440x1082744_908021x1093702_908505x1082625" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_3_3">2Q 2015</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1093697_907440x1082744_908021x997679_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_4_2">1174000</us-gaap:ContractRevenueCost>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1093697_907440x1082744_908021x997679_908505x1082625" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_4_3">2Q 2015</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1093698_907440x1082744_908021x1093703_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_10_2">1002000</us-gaap:ContractRevenueCost>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1093698_907440x1082744_908021x1093703_908505x1082625" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_10_3">3Q 2015</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295244_907440x1082744_908021x1295250_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_5_2">21000</us-gaap:ContractRevenueCost>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295244_907440x1082744_908021x1295250_908505x1082625" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_5_3">3Q 2015</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295245_907440x1082744_908021x1082740_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_6_2">1668000</us-gaap:ContractRevenueCost>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295245_907440x1082744_908021x1082740_908505x1082625" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_6_3">3Q 2015</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295245_907440x1082744_908021x1295251_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_8_2">2481000</us-gaap:ContractRevenueCost>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295245_907440x1082744_908021x1295251_908505x1082625" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_8_3">3Q 2015</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295247_907440x1082744_908021x1295252_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_9_2">564000</us-gaap:ContractRevenueCost>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295247_907440x1082744_908021x1295252_908505x1082625" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_9_3">3Q 2015</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295248_907440x1082744_908021x1082740_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_11_2">554000</us-gaap:ContractRevenueCost>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295248_907440x1082744_908021x1082740_908505x1082625" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_11_3">3Q 2015</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <us-gaap:ContractRevenueCost contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295249_907440x1082744_908021x1082740_908505x1082625" unitRef="iso4217_USD" decimals="-3" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_12_2">5678000</us-gaap:ContractRevenueCost>
  <mpw:DevelopmentProjectsEstimatedCompletionDate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295249_907440x1082744_908021x1082740_908505x1082625" id="id_6193307_828C0299-5775-4AC5-B6F2-20E0E95CF668_12_3">3Q 2016</mpw:DevelopmentProjectsEstimatedCompletionDate>
  <us-gaap:Revenues contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x902145" unitRef="iso4217_USD" decimals="-5" id="id_6193307_16DECFE3-A282-4067-9BBE-72D33EF424B9_3001_1">16300000</us-gaap:Revenues>
  <mpw:NumberOfPartnersSharedRemainingOwnershipPercentage contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_904892x905430" unitRef="Director" decimals="INF" id="id_6193307_521DB8E0-9F6D-49E8-9A0A-0EFF0FDDA678_1001_4">1</mpw:NumberOfPartnersSharedRemainingOwnershipPercentage>
  <mpw:NumberOfDirectFinancingLeases contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_907439x1082624" unitRef="Leases" decimals="INF" id="id_6193307_E1330420-EBF1-4593-AD70-1CD36C6C0579_2_0">5</mpw:NumberOfDirectFinancingLeases>
  <mpw:NumberOfDirectFinancingLeases contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_907439x948370" unitRef="Leases" decimals="INF" id="id_6193307_E1330420-EBF1-4593-AD70-1CD36C6C0579_1_0">15</mpw:NumberOfDirectFinancingLeases>
  <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_907645x976566" id="id_6193307_607196C8-8F0B-49C3-BE09-20BB3032BDE8_1001_3">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
  <mpw:PurchasePeriodOfSharesForUnderwriters contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_907909x1068343" id="id_6193307_0BFB620C-010C-4BB5-A0AF-AE1A96F895BF_1002_2">P30D</mpw:PurchasePeriodOfSharesForUnderwriters>
  <us-gaap:DerivativeNetHedgeIneffectivenessGainLoss contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_910288x904022" unitRef="iso4217_USD" decimals="INF" id="id_6193307_5CE2832B-8ADB-4508-83D3-CECBD7CC8610_1001_0">0</us-gaap:DerivativeNetHedgeIneffectivenessGainLoss>
  <mpw:InterestRateOfInterestRateDerivativeInstrument contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_910288x947542" unitRef="pure" decimals="INF" id="id_6193307_03268AFE-C335-4DA9-BBF5-A854C9D795AD_1005_5">0.05675</mpw:InterestRateOfInterestRateDerivativeInstrument>
  <mpw:MaturityDateOfInterestRateSwap contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_910288x947542" id="id_6193307_03268AFE-C335-4DA9-BBF5-A854C9D795AD_1005_6">October 2016</mpw:MaturityDateOfInterestRateSwap>
  <mpw:MaturityDateOfInterestRateSwap contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_910288x998346" id="id_6193307_03268AFE-C335-4DA9-BBF5-A854C9D795AD_2005_3">July 2016</mpw:MaturityDateOfInterestRateSwap>
  <mpw:EstimatedIncreaseDecreaseInFairValueOfFinancialInstrument contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_910484x936291" unitRef="iso4217_USD" decimals="-3" id="id_6193307_037B2AFD-392D-42D4-B9F7-89577E67950F_1_1">-443000</mpw:EstimatedIncreaseDecreaseInFairValueOfFinancialInstrument>
  <mpw:EstimatedIncreaseDecreaseInFairValueOfFinancialInstrument contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_910484x959717" unitRef="iso4217_USD" decimals="-3" id="id_6193307_037B2AFD-392D-42D4-B9F7-89577E67950F_2_1">443000</mpw:EstimatedIncreaseDecreaseInFairValueOfFinancialInstrument>
  <mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_910720x1049647" id="id_6193307_5EAC5479-4C0D-4410-BFF1-F5BC062D19CC_1001_7">Various</mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime>
  <mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_910720x901310" id="id_6193307_5EAC5479-4C0D-4410-BFF1-F5BC062D19CC_2001_1">Various</mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime>
  <mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_910720x912276" id="id_6193307_5EAC5479-4C0D-4410-BFF1-F5BC062D19CC_3001_0">Variable</mpw:DebtInstrumentDescriptionOfVariableRateBasisPrime>
  <mpw:NumberOfPartnersSharedRemainingOwnershipPercentage contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912620x1063447" unitRef="Employee" decimals="INF" id="id_6193307_521DB8E0-9F6D-49E8-9A0A-0EFF0FDDA678_2001_3">2</mpw:NumberOfPartnersSharedRemainingOwnershipPercentage>
  <us-gaap:EarningsPerShareDiluted contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD_per_shares" decimals="2" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_33">0.17</us-gaap:EarningsPerShareDiluted>
  <dei:DocumentType contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" id="id_6193307_5971E97C-1419-4316-8F57-7E149560F042_1001_6">10-Q</dei:DocumentType>
  <dei:EntityRegistrantName contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" id="id_6193307_6A94DFD6-FD91-454D-B669-5B289045196E_1001_6">MPT Operating Partnership, L.P.</dei:EntityRegistrantName>
  <dei:EntityFilerCategory contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" id="id_6193307_6A94DFD6-FD91-454D-B669-5B289045196E_1001_9">Non-accelerated Filer</dei:EntityFilerCategory>
  <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_E1EF175D-A3DC-4F93-A771-301E2AFC2806_1001_7">657000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_14">42026000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD_per_shares" decimals="2" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_31">0.17</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
  <dei:DocumentPeriodEndDate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" id="id_6193307_5971E97C-1419-4316-8F57-7E149560F042_1001_8">2015-03-31</dei:DocumentPeriodEndDate>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD_per_shares" decimals="0" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_27">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
  <dei:AmendmentFlag contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" id="id_6193307_5971E97C-1419-4316-8F57-7E149560F042_1001_7">false</dei:AmendmentFlag>
  <dei:CurrentFiscalYearEndDate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" id="id_6193307_6A94DFD6-FD91-454D-B669-5B289045196E_1001_8">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentFiscalYearFocus contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" id="id_6193307_5971E97C-1419-4316-8F57-7E149560F042_1001_9">2015</dei:DocumentFiscalYearFocus>
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_E1EF175D-A3DC-4F93-A771-301E2AFC2806_1001_8">203615000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <us-gaap:EarningsPerShareBasic contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD_per_shares" decimals="2" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_28">0.18</us-gaap:EarningsPerShareBasic>
  <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD_per_shares" decimals="2" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_26">0.18</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
  <us-gaap:PartnersCapitalAccountUnitsSaleOfUnits contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="shares" decimals="-5" id="id_6193307_521DB8E0-9F6D-49E8-9A0A-0EFF0FDDA678_3001_1">34500000</us-gaap:PartnersCapitalAccountUnitsSaleOfUnits>
  <dei:EntityCentralIndexKey contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" id="id_6193307_6A94DFD6-FD91-454D-B669-5B289045196E_1001_7">0001524607</dei:EntityCentralIndexKey>
  <us-gaap:CommonStockDividendsPerShareDeclared contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD_per_shares" decimals="INF" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_35">0.22</us-gaap:CommonStockDividendsPerShareDeclared>
  <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD_per_shares" decimals="0" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_32">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
  <dei:DocumentFiscalPeriodFocus contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" id="id_6193307_5971E97C-1419-4316-8F57-7E149560F042_1001_10">Q1</dei:DocumentFiscalPeriodFocus>
  <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="shares" decimals="-3" id="id_6193307_E1EF175D-A3DC-4F93-A771-301E2AFC2806_1001_6">202958000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
  <us-gaap:PaymentsOfOrdinaryDividends contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_24">38461000</us-gaap:PaymentsOfOrdinaryDividends>
  <us-gaap:RepaymentsOfLongTermDebt contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_23">71000</us-gaap:RepaymentsOfLongTermDebt>
  <us-gaap:PaymentsToAcquireLoansReceivable contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_18">80301000</us-gaap:PaymentsToAcquireLoansReceivable>
  <us-gaap:ProfitLoss contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_22">35976000</us-gaap:ProfitLoss>
  <us-gaap:StraightLineRent contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_2">4728000</us-gaap:StraightLineRent>
  <us-gaap:OperatingIncomeLoss contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_13">63710000</us-gaap:OperatingIncomeLoss>
  <us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_4">25578000</us-gaap:InterestAndFeeIncomeLoansCommercialRealEstate>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_9AA113F4-E16A-4379-A90D-F5B1583DA9A0_1001_6">-23111000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:NonoperatingIncomeExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_19">-27734000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:PaymentsToAcquireRealEstate contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_16">165700000</us-gaap:PaymentsToAcquireRealEstate>
  <us-gaap:OtherNonoperatingIncomeExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_15">-796000</us-gaap:OtherNonoperatingIncomeExpense>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_9AA113F4-E16A-4379-A90D-F5B1583DA9A0_1001_2">585000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_9AA113F4-E16A-4379-A90D-F5B1583DA9A0_1001_3">-59593000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
  <us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_3">12555000</us-gaap:CapitalLeasesIncomeStatementDirectFinancingLeaseRevenue>
  <us-gaap:Revenues contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_5">95961000</us-gaap:Revenues>
  <us-gaap:OtherNoncashIncomeExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_10">1290000</us-gaap:OtherNoncashIncomeExpense>
  <us-gaap:NetIncomeLoss contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_24">35897000</us-gaap:NetIncomeLoss>
  <us-gaap:InterestPaid contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_33">22832000</us-gaap:InterestPaid>
  <us-gaap:OtherNonoperatingIncome contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_16">103000</us-gaap:OtherNonoperatingIncome>
  <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_E1EF175D-A3DC-4F93-A771-301E2AFC2806_1001_0">35976000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_9AA113F4-E16A-4379-A90D-F5B1583DA9A0_1001_4">-23032000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_3">15074000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:InterestExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_17">26666000</us-gaap:InterestExpense>
  <us-gaap:ProceedsFromCollectionOfLoansReceivable contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_17">1466000</us-gaap:ProceedsFromCollectionOfLoansReceivable>
  <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_9">1377000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
  <us-gaap:EffectOfExchangeRateOnCash contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_30">-2962000</us-gaap:EffectOfExchangeRateOnCash>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_29">-108031000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:IncomeTaxExpenseBenefit contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_18">375000</us-gaap:IncomeTaxExpenseBenefit>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_20">-291046000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:DepreciationAndAmortization contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_7">14756000</us-gaap:DepreciationAndAmortization>
  <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_9">351000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_25">479966000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_27">-126000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_28">140989000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_11">6239000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:CostsAndExpenses contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_12">32251000</us-gaap:CostsAndExpenses>
  <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_E1EF175D-A3DC-4F93-A771-301E2AFC2806_1001_1">79000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_10">10905000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_13">-6271000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_23">79000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
  <us-gaap:ShareBasedCompensation contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_8">2825000</us-gaap:ShareBasedCompensation>
  <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_9AA113F4-E16A-4379-A90D-F5B1583DA9A0_1001_5">79000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
  <mpw:ProceedsFromLeaseDepositsAndOtherObligationsToTenants contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_26">-15319000</mpw:ProceedsFromLeaseDepositsAndOtherObligationsToTenants>
  <mpw:RevolvingCreditFacilitiesNet contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_22">285000000</mpw:RevolvingCreditFacilitiesNet>
  <mpw:ConstructionInProgressEquipmentAndOther contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_19">46511000</mpw:ConstructionInProgressEquipmentAndOther>
  <mpw:StraightLineRentRevenue contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_5">4728000</mpw:StraightLineRentRevenue>
  <mpw:NumberOfOtherPartners contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="Partner" decimals="INF" id="id_6193307_521DB8E0-9F6D-49E8-9A0A-0EFF0FDDA678_3001_2">3</mpw:NumberOfOtherPartners>
  <mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_E1EF175D-A3DC-4F93-A771-301E2AFC2806_1001_3">35631000</mpw:IncomeLossFromContinuingOperationsLessParticipatingSecuritiesShareInEarnings>
  <mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_E1EF175D-A3DC-4F93-A771-301E2AFC2806_1001_5">35631000</mpw:NetIncomeLessParticipatingSecuritiesShareInEarnings>
  <mpw:RentBilled contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_7D7EE4D8-9C5F-469E-A6A2-7F1B09CBECFA_1001_1">53100000</mpw:RentBilled>
  <mpw:IncreaseDecreaseInInterestAndRentReceivable contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_12">-667000</mpw:IncreaseDecreaseInInterestAndRentReceivable>
  <mpw:RecognitionOfUnearnedIncomeOnDirectFinancingAndSalesTypeLeases contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_8D81546C-960C-4522-B2CB-8538AC4DD736_1001_4">1604000</mpw:RecognitionOfUnearnedIncomeOnDirectFinancingAndSalesTypeLeases>
  <mpw:UndistributedEarningAllocatedToParticipatingSecurities contextRef="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373" unitRef="iso4217_USD" decimals="-3" id="id_6193307_E1EF175D-A3DC-4F93-A771-301E2AFC2806_1001_2">266000</mpw:UndistributedEarningAllocatedToParticipatingSecurities>
  <mpw:PortionOfDebtInstrumentFaceAmount contextRef="eol_PE631979--1510-Q0001_STD_91_20100630_0_910720x901310" unitRef="iso4217_USD" decimals="-6" id="id_6193307_03268AFE-C335-4DA9-BBF5-A854C9D795AD_3001_0">65000000</mpw:PortionOfDebtInstrumentFaceAmount>
  <context id="eol_PE631979--1510-Q0001_STD_91_20100630_0_910720x901310">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2010-04-01</startDate>
      <endDate>2010-06-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_912827x1033373">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_912620x1063447">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mpw:EmployeeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_910720x912276">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_910720x901310">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_910720x1049647">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mpw:TermLoansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_910484x959717">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mpw:MinusHundredBasisPointsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_910484x936291">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mpw:PlusHundredBasisPointsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_910288x998346">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mpw:InterestRateContractOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_910288x947542">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mpw:InterestRateContractTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_910288x904022">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_907909x1068343">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mpw:PublicOfferingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_907645x976566">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mpw:IntangibleLeaseAssetsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_907439x948370">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_907439x1082624">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:PrimeFacilitiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_904892x905430">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:DirectorMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x902145">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:EuropeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295249_907440x1082744_908021x1082740_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:HoustonTxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErVintagePreserveMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295248_907440x1082744_908021x1082740_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:HoustonTxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErVictoryLakesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295247_907440x1082744_908021x1295252_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:GlendaleAzMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErGlendaleMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295245_907440x1082744_908021x1295251_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:GilbertAzMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErConroeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295245_907440x1082744_908021x1082740_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:HoustonTxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErConroeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1295244_907440x1082744_908021x1295250_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:AuroraCoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErAuroraMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1093698_907440x1082744_908021x1093703_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:MckinneyTxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErMckinneyMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1093697_907440x1082744_908021x997679_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:DenverCoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErDenverFortyEighthMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1093696_907440x1082744_908021x1093702_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:ConverseTxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErConverseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1093695_907440x1082744_908021x1093701_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:ChandlerAzMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErChandlerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1093693_907440x1082744_908021x1093700_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:CarrolltonTxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErCarrolltonMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1092391_907440x1082744_908021x991433_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:VariousMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceEmergencyRoomsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_904842x1085855_907440x1085859_908021x1085858_908505x1087026">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:HooverAlMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:MedicalWestAnAffiliateOfUabMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalAndMedicalOfficeBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:UabMedicalWestMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x907273_904842x906348_908551x905169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x907273_904842x906342_908551x905169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x907273_904842x903009_908551x905169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x907273_904842x902145_908551x905169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:EuropeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x906990_907439x948370_908551x904419">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x906990_907439x948370">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x906990_907439x937635_908551x904419">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:PrimeHealthCareServicesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x906990_907439x937635">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:PrimeHealthCareServicesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x906990_907439x925328_908551x905169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:MedianMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_903554x906990_907439x925328_908551x904419">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:MedianMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_901822x992702">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mpw:TimeBasedAwardsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_901822x905956">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0_901822x1064668">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mpw:MultiYearPerformanceBasedAwardsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20150331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <startDate>2015-01-01</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20140331_0_912827x1033373">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20140331_0_910288x904022">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20140331_0_907909x1026999">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mpw:MarketEquityOfferingProgramMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20140331_0_907676x1295251">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mpw:GilbertAzMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20140331_0_907645x976566">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mpw:IntangibleLeaseAssetsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20140331_0_904842x902145">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:EuropeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20140331_0_903554x906990_907439x948370_908551x904419">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20140331_0_903554x906990_907439x937635_908551x904419">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:PrimeHealthCareServicesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20140331_0_901822x992702">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mpw:TimeBasedAwardsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20140331_0_901822x905956">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20140331_0_901822x1064668">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mpw:MultiYearPerformanceBasedAwardsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_90_20140331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_365_20141231_0_910720x912276">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_365_20141231_0_910720x901310">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_365_20141231_0_910720x1049647">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mpw:TermLoansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_365_20141231_0_903554x907273_904842x906348_908551x905169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_365_20141231_0_903554x907273_904842x906342_908551x905169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_365_20141231_0_903554x907273_904842x902145_908551x905169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:EuropeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_365_20141231_0_903554x906990_907439x948370">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_365_20141231_0_903554x906990_907439x937635">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:PrimeHealthCareServicesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_365_20141231_0_903554x906990_907439x925328_908551x905169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:MedianMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_31_20140131_0_907909x1026999">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mpw:MarketEquityOfferingProgramMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-01-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_1_20150114_0_907909x1068343">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mpw:PublicOfferingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-14</startDate>
      <endDate>2015-01-14</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_1_20150331_0_904377x959676_907440x1082744_910289x948168">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">mpw:MarkToMarketFairValueAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFourteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-03-31</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_1_20150331_0_904377x959676_907440x1082744">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFourteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-03-31</startDate>
      <endDate>2015-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_1_20140331_0_904377x959676_907440x1082744">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFourteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-03-31</startDate>
      <endDate>2014-03-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_1_20150430_0_902887x904859_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-04-30</startDate>
      <endDate>2015-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_1_20150430_0_902887x904859_904377x1041555_907439x925328">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:MedianMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-04-30</startDate>
      <endDate>2015-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_1_20150430_0_901032x909105_902887x904859_904377x1041555_907439x925328">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:MedianMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-04-30</startDate>
      <endDate>2015-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_1_20150430_0_901032x907457_902887x904859_904377x1041555_907439x925328">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:MedianMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-04-30</startDate>
      <endDate>2015-04-30</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_1_20140311_0_907909x1068343">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mpw:PublicOfferingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2014-03-11</startDate>
      <endDate>2014-03-11</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_1_20120301_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <startDate>2012-03-01</startDate>
      <endDate>2012-03-01</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_1_20150227_0_904377x1041555_904842x953825_907439x948370_907440x1092397">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:InpatientRehabilitationHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:WeslacoTexasMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-02-27</startDate>
      <endDate>2015-02-27</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_1_20150213_0_904377x1041555_904842x902958_907440x1082744">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:KS</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-02-13</startDate>
      <endDate>2015-02-13</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_1_20150131_0_904377x1041555_907439x925328">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:MedianMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <startDate>2015-01-31</startDate>
      <endDate>2015-01-31</endDate>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150114_0_907909x1068343">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mpw:PublicOfferingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-01-14</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20141231_0_912827x1033373">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20141231_0_912455x903927_912827x1033373">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:GeneralPartnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20141231_0_912455x1012147_912827x1033373">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">mpw:LtipUnitsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20141231_0_911970x911063">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EligibleItemOrGroupForFairValueOptionAxis">us-gaap:SeniorDebtObligationsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20141231_0_911379x904172">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesByTypeAxis">us-gaap:MortgageLoansOnRealEstateMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20141231_0_910720x975098">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mpw:TwoThousandThirteenSeniorUnsecuredNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20141231_0_910720x912276">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20141231_0_910720x901310">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20141231_0_910720x1082633">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mpw:TwoThousandFourteenSeniorUnsecuredNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20141231_0_910720x1049647">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mpw:TermLoansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20141231_0_910720x1015151">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mpw:TwoThousandTwelveSeniorUnsecuredNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20141231_0_910288x910614">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20141231_0_910288x904022">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20141231_0_907910x901931_912827x1033373">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20141231_0_903417x929207">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">mpw:AcquisitionLoanMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20141231_0_903417x1061338">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">mpw:WorkingCapitalLoansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20141231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20131231_0_912827x1033373">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20131231_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <instant>2013-12-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_912827x1033373">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_912455x903927_912827x1033373">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">us-gaap:GeneralPartnerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_912455x1012147_912827x1033373">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PartnerTypeOfPartnersCapitalAccountAxis">mpw:LtipUnitsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_911970x911063">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:EligibleItemOrGroupForFairValueOptionAxis">us-gaap:SeniorDebtObligationsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_911379x904172">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesByTypeAxis">us-gaap:MortgageLoansOnRealEstateMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_910720x975098">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mpw:TwoThousandThirteenSeniorUnsecuredNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_910720x912276">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_910720x901310">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_910720x1082633">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mpw:TwoThousandFourteenSeniorUnsecuredNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_910720x1049647">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mpw:TermLoansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_910720x1015151">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">mpw:TwoThousandTwelveSeniorUnsecuredNotesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_910288x998346">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mpw:InterestRateContractOneMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_910288x910614">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_910288x904022">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_910113x905894">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_908551x905169">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AssetsTotalMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_907910x901931_912827x1033373">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_907909x1026999">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mpw:MarketEquityOfferingProgramMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_907676x1295251">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mpw:GilbertAzMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_907645x929995">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mpw:OtherLoansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_907645x929480">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mpw:NetInvestmentInDirectFinancingLeasesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_907645x907375">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_907645x905205">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_907439x1040992">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:ErnestHealthIncAndOtherAcquisitionsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_907439x1033784">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:FlorenceAcuteCareFacilityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_907178x902141_907181x905531_910113x905894">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_907178x902141">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_906604x1067963">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:VariableInterestEntitiesByClassificationOfEntityAxis">mpw:MortgageAndOtherLoansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1295249_907440x1082744_908021x1082740_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:HoustonTxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErVintagePreserveMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1295248_907440x1082744_908021x1082740_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:HoustonTxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErVictoryLakesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1295247_907440x1082744_908021x1295252_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:GlendaleAzMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErGlendaleMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1295245_907440x1082744_908021x1295251_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:GilbertAzMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErConroeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1295245_907440x1082744_908021x1082740_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:HoustonTxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErConroeMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1295244_907440x1082744_908021x1295250_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:AuroraCoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErAuroraMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1093698_907440x1082744_908021x1093703_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:MckinneyTxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErMckinneyMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1093697_907440x1082744_908021x997679_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:DenverCoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErDenverFortyEighthMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1093696_907440x1082744_908021x1093702_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:ConverseTxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErConverseMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1093695_907440x1082744_908021x1093701_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:ChandlerAzMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErChandlerMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1093693_907440x1082744_908021x1093700_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:CarrolltonTxMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceErCarrolltonMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1092391_907440x1082744_908021x991433_908505x1082625">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:VariousMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:AdeptusHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:FirstChoiceEmergencyRoomsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_904842x1085855_907440x1085859_908021x1085858_908505x1087026">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:EntityByLocationAxis">mpw:HooverAlMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalUnitsByClassAxis">mpw:MedicalWestAnAffiliateOfUabMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalAndMedicalOfficeBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">mpw:UabMedicalWestMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_904377x925328">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:MedianMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_904377x1012489_907439x963808_907645x901808">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:FirstChoiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetUnderConstructionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:DevelopmentActivitiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_904377x1012489_907439x963808">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:FirstChoiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:DevelopmentActivitiesMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_903455x912287">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AssetsSoldUnderAgreementsToRepurchaseAxis">us-gaap:LoansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_903417x929207">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">mpw:AcquisitionLoanMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_903417x1061338">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">mpw:WorkingCapitalLoansMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_902967x929995_907178x929207_907181x905531">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="invest:InvestmentAxis">mpw:OtherLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">mpw:AcquisitionLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_902967x1024957_906116x904172_907181x905531">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="invest:InvestmentAxis">mpw:MortgageLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentAxis">us-gaap:MortgageLoansOnRealEstateMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0_901822x999402">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mpw:EquityIncentivePlanMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <instant>2015-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20140331_0_912827x1033373">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mpw:MptOperatingPartnershipLPMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20140331_0_907909x1026999">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mpw:MarketEquityOfferingProgramMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20140331_0_907645x976566">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mpw:IntangibleLeaseAssetsMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20140331_0_907645x907375">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20140331_0_907645x905205">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20140331_0_902891x904047_907909x1026999">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mpw:MarketEquityOfferingProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20140331_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <instant>2014-03-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20140311_0_907909x1068343">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mpw:PublicOfferingMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-03-11</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20130306_0_907439x1033784">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:FlorenceAcuteCareFacilityMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2013-03-06</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20120301_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <instant>2012-03-01</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150508_0">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
    </entity>
    <period>
      <instant>2015-05-08</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150213_0_904377x1041555_904842x902958_907440x1082744">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorPropertyClassAxis">mpw:AcuteCareHospitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">stpr:KS</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-02-13</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20150131_0_904377x1041555_907439x925328">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:MajorCustomersAxis">mpw:MedianMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RealEstatePropertiesAxis">mpw:TwoThousandFifteenMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2015-01-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20140131_0_901032x907457_907909x1026999">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mpw:MarketEquityOfferingProgramMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2014-01-31</instant>
    </period>
  </context>
  <context id="eol_PE631979--1510-Q0001_STD_0_20111031_0_910288x947542">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001287865</identifier>
      <segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mpw:InterestRateContractTwoMember</xbrldi:explicitMember></segment>
    </entity>
    <period>
      <instant>2011-10-31</instant>
    </period>
  </context>
  <unit id="iso4217_USD">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="iso4217_EUR">
    <measure>iso4217:EUR</measure>
  </unit>
  <unit id="RenewalOptions">
    <measure>mpw:RenewalOptions</measure>
  </unit>
  <unit id="shares">
    <measure>shares</measure>
  </unit>
  <unit id="iso4217_USD_per_shares">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="Facility">
    <measure>mpw:Facility</measure>
  </unit>
  <unit id="pure">
    <measure>pure</measure>
  </unit>
  <unit id="Investment">
    <measure>mpw:Investment</measure>
  </unit>
  <unit id="Leases">
    <measure>mpw:Leases</measure>
  </unit>
  <unit id="Hospital">
    <measure>mpw:Hospital</measure>
  </unit>
  <unit id="Director">
    <measure>mpw:Director</measure>
  </unit>
  <unit id="Employee">
    <measure>mpw:Employee</measure>
  </unit>
  <unit id="Partner">
    <measure>mpw:Partner</measure>
  </unit>
</xbrl>
